HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with portal hypertension; total protein ascites 1.7 vs.
   serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
   16:36
   ------ Protected Section ------
   Agree with findings and plan as outline in excellent MS4 note by
   Dryzmalski.
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) 4058**], MD
   on:[**2134-5-23**] 08:06 ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) **] from [**2134-5-21**] and [**Doctor Last Name 4058**]
   [**2134-5-22**].
   I would add the following remarks:
   Medical Decision Making
   She has not had significant bradycardia here and etiology of transient
   bradycardia may be some degree of contribution from her infection.  I
   suspect that she will not need a pacemaker but will obtain EP input.
   Hold dopamine.   Consult renal service regarding management of anuric
   renal failure.  Her Aortic stenosis does not seem to be a major
   hemodynamic contributor.  Treat for spontaneous bacterial peritonitis.
   Date of service [**2134-5-22**]  Time spent with patient 40 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) **], MD
   on:[**2134-5-23**] 09:56 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with portal hypertension; total protein ascites 1.7 vs.
   serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
   16:36
   ------ Protected Section ------
   Agree with findings and plan as outline in excellent MS4 note by
   Dryzmalski.
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) 4058**], MD
   on:[**2134-5-23**] 08:06 ------
   Cardiology Teaching Physician Note
   On this day I saw, examined and was physically present with the
   resident / fellow for the key portions of the services provided. I
   agree with the above note and plans.
   I have also reviewed the notes of Dr(s). [**Name (NI) **] from [**2134-5-21**] and [**Doctor Last Name 4058**]
   [**2134-5-22**].
   I would add the following remarks:
   Medical Decision Making
   She has not had significant bradycardia here and etiology of transient
   bradycardia may be some degree of contribution from her infection.  I
   suspect that she will not need a pacemaker but will obtain EP input.
   Hold dopamine.   Consult renal service regarding management of anuric
   renal failure.  Her Aortic stenosis does not seem to be a major
   hemodynamic contributor.  Treat for spontaneous bacterial peritonitis.
   Date of service [**2134-5-22**]  Time spent with patient 40 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) **], MD
   on:[**2134-5-23**] 09:56 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 77-year-old female with a history of CAD s/p triple CABG, cirrhosis, DMII, HTN, and CRI. She was admitted to the ICU with new findings of severe AS, bradycardia, hypotension, leukocytosis, and ARF. The patient's increasing abdominal girth is due to increasing peritoneal ascites, and her shortness of breath is likely caused by the accumulation of ascites in her lungs and chest wall.

The patient's ascites is consistent with portal hypertension, and the high gradient SAAG suggests that the ascites is due to cirrhosis. The patient's cirrhosis is likely caused by an unknown etiology, and her calculated MELD score is 23, which is associated with a 90% survival rate at 3 months.

The patient's acute renal failure is likely due to ATN, and her creatinine has risen to 3.5 mg/dL. Her urine sodium is 20, suggesting prerenal failure. The patient's anemia is likely due to GI bleeding, and her hypotension has resolved.

The patient's aortic stenosis is severe, with a valve area of 0.9 cm2, and her EF is preserved at 60%. However, her cardiac biomarkers were negative at the outside hospital.

The patient's medical complications include:

1. Spontaneous bacterial peritonitis (SBP): The patient has a high WBC count and a low ascitic fluid protein concentration, consistent with SBP. She was started on ceftriaxone 1g IV daily x5 days.
2. Acute on chronic renal failure (ATN): The patient's creatinine has risen to 3.5 mg/dL, and her urine sodium is 20, suggesting prerenal failure. She will be monitored for further decline in renal function.
3. Anemia: The patient's anemia is likely due to GI bleeding, and she was put on a PPI and a type and screen was sent.
4. Hypotension: The patient's hypotension has resolved, and she may have been dehydrated and/or overmedicated.
5. Aortic stenosis: The patient's aortic stenosis is severe, and she will need further evaluation and management.

The patient's treatment plan includes:

1. Ceftriaxone 1g IV daily x5 days for SBP.
2. Albumin 1.5g/kg daily for 2 days to help with ascites and renal failure.
3. Hold beta-blocker and calcium-channel blocker due to bradycardia and hypotension.
4. Monitor for further decline in renal function and consider nephrology consult.
5. Guaiac stool to check for GI bleeding.
6. Hold anti-hypertensives and continue aspirin 325mg PO daily.
7. Continue simvastatin 20mg PO daily.
8. Hold lasix and consider renal service consultation regarding management of anuric renal failure.
9. Consult EP for evaluation of bradycardia and potential pacemaker placement.

The patient's prognosis is guarded due to her multiple medical complications, and her family should be informed of her condition and treatment plan."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. We did not get an EKG so we cannot assess fully the rhythm,
   but the outside hospital EKGs suggest junctional rhythm given the lack
   of P waves. This is most likely due to carvedilol
toxicity.
 Given
   that the patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          Will consider abx if has positive infectious work-up
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. We did not get an EKG so we cannot assess fully the rhythm,
   but the outside hospital EKGs suggest junctional rhythm given the lack
   of P waves. This is most likely due to carvedilol
toxicity.
 Given
   that the patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          Will consider abx if has positive infectious work-up
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient's conditions and potential medical complications are as follows:

1. **Ascites and Spontaneous Bacterial Peritonitis (SBP)**: The patient has a large amount of ascites, which was diagnosed as SBP due to the presence of WBCs and low protein concentration in the peritoneal fluid. Treatment includes antibiotics (ceftriaxone) and albumin infusion to reduce mortality rates.
2. **Aortic Stenosis (AS)**: The patient has newly diagnosed severe AS with a valve area of 0.9 cm2, which is likely causing her shortness of breath and dyspnea. The plan is to continue antibiotics for SBP and then evaluate the patient for valvuloplasty or aortic valve replacement.
3. **Bradycardia**: The patient's heart rate has dropped to the 40s, which is likely due to carvedilol toxicity. The plan is to hold carvedilol and consider pacemaker placement.
4. **Acute on Chronic Renal Failure (ATN)**: The patient has acute kidney injury (AKI) superimposed on chronic kidney disease (CKD). The differential diagnosis includes ATN secondary to prerenal etiology, medications, and hepatorenal syndrome. The plan is to continue IV albumin, monitor creatinine daily, and consider nephrology consult.
5. **Anemia**: The patient's hematocrit has dropped from 32 to 25, which may be due to gastrointestinal bleeding. The plan is to guaiac stool and consider transfusion.
6. **Hypotension**: The patient's blood pressure has resolved, and she is no longer on dopamine. The plan is to hold anti-hypertensives and consider antibiotics if the infectious work-up is positive.
7. **Coronary Artery Disease (CAD)**: The patient has CAD with a history of triple CABG. The plan is to continue aspirin, hold beta-blockers, and continue simvastatin.
8. **Pump Failure**: The patient has preserved left ventricular ejection fraction (LVEF) but new findings of severe AS and hypotension requiring dopamine infusion. The plan is to hold beta-blockers and consider restarting furosemide when renal function improves.
9. **Leukocytosis**: The patient has leukocytosis with no clear source of infection. The differential diagnosis includes aspiration pneumonia, SBP, and UTI. The plan is to obtain a CXR, UA, urine culture, blood cultures, and diagnostic paracentesis.

Potential medical complications to watch for include:

1. Worsening of ascites and SBP
2. Development of hepatorenal syndrome
3. Progression of aortic stenosis
4. Worsening of kidney function
5. Gastrointestinal bleeding
6. Infection (e.g., pneumonia, UTI)
7. Cardiac complications (e.g., heart failure, arrhythmias)
8. Respiratory complications (e.g., ARDS, respiratory failure)
9. Sepsis or septic shock

It is essential to continue monitoring the patient's vital signs, laboratory results, and clinical status to identify any potential complications early and intervene promptly."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. We did not get an EKG so we cannot assess fully the rhythm,
   but the outside hospital EKGs suggest junctional rhythm given the lack
   of P waves. This is most likely due to carvedilol
toxicity.
 Given
   that the patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute on
   chronic renal failure due to ATN from hypotension during her episodes
   of supra-therapeutic drug action. We
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. We did not get an EKG so we cannot assess fully the rhythm,
   but the outside hospital EKGs suggest junctional rhythm given the lack
   of P waves. This is most likely due to carvedilol
toxicity.
 Given
   that the patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute on
   chronic renal failure due to ATN from hypotension during her episodes
   of supra-therapeutic drug action. We
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 77-year-old woman with a history of CAD, cirrhosis, DMII, and HTN, who was transferred to the ICU from another hospital with new findings of severe AS, bradycardia, hypotension, leukocytosis, and ARF. She has been diagnosed with SBP and is being treated with ceftriaxone and albumin. The patient's ascites is thought to be due to portal hypertension secondary to cirrhosis. She has a high MELD score and a CHILDS classification of 31%, indicating a high risk for mortality if she were to undergo surgery.

Potential Medical Complications:

1. Aortic Stenosis: The patient has severe AS, which may contribute to her dyspnea and may require intervention.
2. Bradycardia: The patient's bradycardia may be due to carvedilol toxicity, and she may require pacemaker placement.
3. Acute on Chronic Renal Failure: The patient's creatinine level has increased, and she may require dialysis.
4. Sepsis: The patient has leukocytosis and is at risk for developing sepsis.
5. Ascites: The patient's ascites may worsen if not properly managed, leading to respiratory and cardiovascular complications.
6. Hypotension: The patient's hypotension may be due to cardiogenic or septic shock, and she may require vasopressors.
7. Liver Failure: The patient's cirrhosis may progress to liver failure, leading to increased mortality.
8. Respiratory Failure: The patient's ascites and respiratory compromise may lead to respiratory failure.

Recommendations:

1. Continue ceftriaxone and albumin for SBP treatment.
2. Monitor the patient's ascites and adjust fluid management accordingly.
3. Consider intervention for aortic stenosis, including valvuloplasty or AVR.
4. Manage the patient's bradycardia with atropine and consider pacemaker placement.
5. Continue to monitor the patient's renal function and consider dialysis if necessary.
6. Monitor the patient's leukocytosis and adjust antibiotic treatment accordingly.
7. Consider prophylactic antibiotics for SBP and other infections.
8. Monitor the patient's liver function and adjust treatment accordingly.

ICU Care Plan:

1. Monitor vital signs, including heart rate, blood pressure, and oxygen saturation.
2. Monitor fluid balance and adjust fluid management accordingly.
3. Monitor renal function and adjust treatment accordingly.
4. Monitor liver function and adjust treatment accordingly.
5. Monitor for signs of sepsis and adjust treatment accordingly.
6. Monitor for signs of respiratory failure and adjust treatment accordingly.
7. Monitor for signs of liver failure and adjust treatment accordingly.
8. Consider prophylactic antibiotics for SBP and other infections.

Nutrition Plan:

1. Provide a low-sodium diet and fluid restriction.
2. Monitor the patient's nutritional status and adjust diet accordingly.
3. Consider enteral nutrition if necessary.

Glycemic Control Plan:

1. Monitor the patient's blood glucose levels and adjust treatment accordingly.
2. Provide insulin as needed to maintain glycemic control.

Lines:

1. Monitor the patient's lines and adjust treatment accordingly.

Prophylaxis:

1. Provide prophylactic antibiotics for SBP and other infections.
2. Provide prophylactic anticoagulation for DVT and VAP.
3. Provide prophylactic acid suppression for stress ulcer.

Code Status:

1. The patient has full code status.

Disposition:

1. The patient will be transferred to the CCU for further management."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Cipro 750 mg qweek starting after ceftriaxone is
   discontinued
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Cipro 750 mg qweek starting after ceftriaxone is
   discontinued
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is a 77-year-old female with a history of CAD s/p triple CABG, cirrhosis, DMII, HTN, and CRI. She was transferred from another hospital with new findings of severe AS, bradycardia, hypotension, leukocytosis, and ARF. The patient has been diagnosed with SBP, and an ultrasound-guided paracentesis was performed to remove 1.4L of peritoneal fluid. The ascites is consistent with portal hypertension, and the patient has been started on ceftriaxone and albumin to treat the SBP.

The patient has also been diagnosed with severe AS, and a TTE showed a valve area of 0.9cm2, peak gradient ~80, and mean gradient ~50. Given the patient's current infection and lack of severe symptoms related to AS, aggressive intervention is delayed until the infection is cleared.

The patient's other medical conditions include diabetes, type II, and chronic renal failure. She has been started on insulin and has a history of hypotension.

Potential medical complications that can arise include:

1. Sepsis: The patient's SBP and leukocytosis increase the risk of developing sepsis.
2. Aortic stenosis: The patient's severe AS can lead to symptoms such as dyspnea, angina, and syncope, and may require intervention.
3. Chronic renal failure: The patient's current ARF can progress to chronic renal failure if not managed properly.
4. Hepatic encephalopathy: The patient's cirrhosis and ascites increase the risk of developing hepatic encephalopathy.
5. Respiratory failure: The patient's chronic obstructive pulmonary disease (COPD) and ascites increase the risk of developing respiratory failure.
6. Cardiac failure: The patient's aortic stenosis and chronic renal failure increase the risk of developing cardiac failure.
7. Infection: The patient's ascites and SBP increase the risk of developing secondary infections.
8. Bleeding: The patient's ascites and SBP increase the risk of bleeding, especially if the patient develops coagulopathy.

To mitigate these complications, the patient should be closely monitored for signs of sepsis, aortic stenosis, chronic renal failure, hepatic encephalopathy, respiratory failure, cardiac failure, infection, and bleeding. The patient should also be managed with antibiotics, diuretics, and other medications as necessary to treat her conditions."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, which suggests peritonitis.
   Measurement of the ascetic fluid total protein concentration assists in
   differentiating SBP from secondary bacterial peritonitis, where lowest
   protein concentration correlates with a highest risk of developing SBP
   because of low concentrations of opsonins.
   most consistent with spontaneous bacterial peritonitis (SBP).
   The patient was started on ceftriaxone 1g IV daily x5 days (day
   1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin 1.0g/kg on day 3
   ([**2134-5-23**]). Afterwards, she will need to regular cipro for the rest of
   her life to prevent recurrence.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   Because the vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis, it is most likely that cirrhosis is the cause
   in our patient.
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7713**]
   2. [**URL 7713**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, which suggests peritonitis.
   Measurement of the ascetic fluid total protein concentration assists in
   differentiating SBP from secondary bacterial peritonitis, where lowest
   protein concentration correlates with a highest risk of developing SBP
   because of low concentrations of opsonins.
   most consistent with spontaneous bacterial peritonitis (SBP).
   The patient was started on ceftriaxone 1g IV daily x5 days (day
   1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin 1.0g/kg on day 3
   ([**2134-5-23**]). Afterwards, she will need to regular cipro for the rest of
   her life to prevent recurrence.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   Because the vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis, it is most likely that cirrhosis is the cause
   in our patient.
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7713**]
   2. [**URL 7713**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 77-year-old female with a history of CAD, cirrhosis, DMII, HTN, and CRI, who was transferred to the ICU with new findings of severe AS, bradycardia, hypotension, leukocytosis, and ARF. She has increasing abdominal girth due to peritoneal ascites, which was confirmed by ultrasound-guided paracentesis. The ascitic fluid total protein concentration was 1.7 g/dL, which is consistent with a transudate. The patient was started on ceftriaxone 1g IV daily x5 days and albumin 1.5g/kg.

Potential Medical Complications:

1. Spontaneous Bacterial Peritonitis (SBP): The patient has a high risk of developing SBP due to the presence of ascites and leukocytosis.
2. Aortic Stenosis: The patient has severe AS, which may contribute to her dyspnea and may require intervention.
3. Cardiac Arrest: The patient's bradycardia and hypotension may increase her risk of cardiac arrest.
4. Respiratory Failure: The patient's ascites and pleural effusion may lead to respiratory failure.
5. Renal Failure: The patient's creatinine level is elevated, and she has acute on chronic renal failure, which may worsen with continued fluid overload.
6. Sepsis: The patient's leukocytosis and hypotension may indicate sepsis, which may require prompt antibiotic treatment.
7. Liver Failure: The patient has cirrhosis, which may worsen with continued liver damage.
8. Gastrointestinal Bleeding: The patient's ascites and portal hypertension may increase her risk of gastrointestinal bleeding.

Recommendations:

1. Continue antibiotics for SBP and monitor for signs of sepsis.
2. Consider intervention for aortic stenosis, such as valvuloplasty or AVR.
3. Monitor cardiac rhythm and adjust therapy as needed to prevent cardiac arrest.
4. Manage ascites with diuretics and albumin infusions.
5. Monitor renal function and adjust fluid management to prevent worsening renal failure.
6. Consider antibiotic treatment for suspected sepsis.
7. Monitor liver function and consider liver transplantation if necessary.
8. Monitor gastrointestinal bleeding risk and consider prophylactic therapy."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, most consistent with spontaneous bacterial
   peritonitis (SBP). The patient was started on ceftriaxone 1g IV daily
   x5 days (day 1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin
   1.0g/kg on day 3 ([**2134-5-23**]). Afterwards, she will need to regular cipro
   for the rest of her life to prevent recurrence.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). Top of the differential diagnosis for portal
   hypertension includes cirrhosis, CHF, and alcoholic hepatitis. Because
   our patient has SBP,
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7713**]
   2. [**URL 7713**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, most consistent with spontaneous bacterial
   peritonitis (SBP). The patient was started on ceftriaxone 1g IV daily
   x5 days (day 1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin
   1.0g/kg on day 3 ([**2134-5-23**]). Afterwards, she will need to regular cipro
   for the rest of her life to prevent recurrence.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). Top of the differential diagnosis for portal
   hypertension includes cirrhosis, CHF, and alcoholic hepatitis. Because
   our patient has SBP,
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7713**]
   2. [**URL 7713**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 77-year-old female with a history of coronary artery disease, cirrhosis, type II diabetes, hypertension, and chronic renal insufficiency. She was admitted to the ICU with new findings of severe aortic stenosis, bradycardia, hypotension, leukocytosis, and acute renal failure. The patient's ascites is attributed to portal hypertension secondary to cirrhosis. She was started on ceftriaxone for spontaneous bacterial peritonitis and albumin infusion for ascites management. The patient has a complex medical history, including coronary artery disease, cirrhosis, and type II diabetes, which may contribute to her current condition.

Potential Medical Complications:

1. Respiratory failure: The patient's shortness of breath may be related to her ascites and may worsen if not managed properly.
2. Cardiac complications: The patient's severe aortic stenosis may lead to cardiac arrest, heart failure, or arrhythmias.
3. Renal failure: The patient's acute renal failure may worsen if not managed properly, leading to electrolyte imbalances, acidosis, and anemia.
4. Infection: The patient's leukocytosis and ascites may be indicative of an underlying infection, which may spread to other parts of the body if not treated promptly.
5. Gastrointestinal bleeding: The patient's cirrhosis and portal hypertension may increase her risk of gastrointestinal bleeding.
6. Hepatic encephalopathy: The patient's cirrhosis and ascites may increase her risk of developing hepatic encephalopathy.
7. Malnutrition: The patient's ascites and gastrointestinal bleeding may lead to malnutrition if not managed properly.
8. Electrolyte imbalances: The patient's ascites and diuretic therapy may lead to electrolyte imbalances, which may worsen her cardiac and renal function.

Recommendations:

1. Continue to monitor the patient's respiratory status and provide oxygen therapy as needed.
2. Manage the patient's cardiac status by optimizing her cardiac output and controlling her blood pressure.
3. Continue to manage the patient's ascites and portal hypertension with albumin infusion and diuretic therapy.
4. Monitor the patient's renal function and adjust her diuretic therapy as needed.
5. Treat the patient's infection promptly with antibiotics and monitor her response to therapy.
6. Monitor the patient's gastrointestinal bleeding risk and provide prophylactic therapy as needed.
7. Monitor the patient's nutritional status and provide enteral nutrition as needed.
8. Monitor the patient's electrolyte imbalances and adjust her therapy as needed."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth was due to ascites.
   Her shortness of breath was probably related to the ascites in two
   ways: (a) via a restrictive process where it is harder for her to
   inhale due to the pressure against her lungs and chest wall; and (b)
   via SBP, which increases her white count, causing anion-gap metabolic
   acidosis due to increased CO2 production, causing tachypnea to blow off
   excess CO2, causing discomfort of breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, most consistent with spontaneous bacterial
   peritonitis (SBP). The patient was started on ceftriaxone 1g IV daily
   x5 days (day 1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin
   1.0g/kg on day 3 ([**2134-5-23**]). Afterwards, she will need to regular cipro
   for the rest of her life to prevent recurrence.
   The patient
s SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3 (high gradient SAAG is >1.1), which has 97% accuracy for
   predicting portal hypertension (see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]). Top of the differential diagnosis for portal
   hypertension includes cirrhosis, CHF, and alcoholic hepatitis. Because
   our patient has SBP,
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7711**]
   2. [**URL 7712**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth was due to ascites.
   Her shortness of breath was probably related to the ascites in two
   ways: (a) via a restrictive process where it is harder for her to
   inhale due to the pressure against her lungs and chest wall; and (b)
   via SBP, which increases her white count, causing anion-gap metabolic
   acidosis due to increased CO2 production, causing tachypnea to blow off
   excess CO2, causing discomfort of breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, most consistent with spontaneous bacterial
   peritonitis (SBP). The patient was started on ceftriaxone 1g IV daily
   x5 days (day 1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin
   1.0g/kg on day 3 ([**2134-5-23**]). Afterwards, she will need to regular cipro
   for the rest of her life to prevent recurrence.
   The patient
s SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3 (high gradient SAAG is >1.1), which has 97% accuracy for
   predicting portal hypertension (see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]). Top of the differential diagnosis for portal
   hypertension includes cirrhosis, CHF, and alcoholic hepatitis. Because
   our patient has SBP,
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7711**]
   2. [**URL 7712**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 77-year-old female with a complex medical history, including coronary artery disease, cirrhosis, diabetes mellitus type II, hypertension, and chronic renal insufficiency. She was recently transferred to the ICU from an outside hospital with new findings of severe aortic stenosis, bradycardia, hypotension, and leukocytosis.

The patient has undergone an ultrasound-guided paracentesis, which revealed 5L of ascites, and the peritoneal fluid was consistent with spontaneous bacterial peritonitis (SBP). She has been started on ceftriaxone 1g IV daily x5 days and albumin 1.5g/kg.

The patient's laboratory results show:

* White blood cell count (WBC): 19.0
* Hemoglobin (Hb): 8.8 g/dL
* Platelet count (Plt): 172
* Creatinine (Cr): 3.3 mg/dL
* Blood urea nitrogen (BUN): 27.5%
* Serum albumin: 3.7 g/dL
* Total protein: 6.5 g/dL
* Ascitic fluid total protein: 1.7 g/dL

The patient's medical complications include:

* Severe aortic stenosis with a valve area of 0.9 cm2
* Bradycardia with a heart rate in the 30s
* Hypotension requiring dopamine infusion
* Leukocytosis with a WBC count of 19.0
* Acute on chronic renal failure with a creatinine of 3.3 mg/dL
* Ascites with a serum-ascites albumin gradient (SAAG) of 2.3, consistent with transudate

The patient's potential medical complications include:

* Cardiac complications due to severe aortic stenosis, including heart failure, arrhythmias, and sudden cardiac death
* Respiratory complications due to ascites, including respiratory failure and pulmonary edema
* Renal complications due to acute on chronic renal failure, including worsening renal function and electrolyte imbalances
* Infection complications due to SBP, including sepsis and multi-organ failure
* Hepatic complications due to cirrhosis, including portal hypertension, bleeding, and encephalopathy

The patient's management plan includes:

* Continued treatment for SBP with ceftriaxone and albumin
* Monitoring of cardiac function and management of bradycardia and hypotension
* Close monitoring of renal function and management of acute on chronic renal failure
* Management of ascites with diuretics and paracentesis as needed
* Prophylaxis for DVT and stress ulcer
* Close monitoring of blood glucose levels and management of diabetes mellitus type II

Overall, the patient's complex medical history and current condition require close monitoring and management to prevent further complications and improve her outcomes."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. We did not get an EKG so we cannot assess fully the rhythm,
   but the outside hospital EKGs suggest junctional rhythm given the lack
   of P waves. This is most likely due to carvedilol
toxicity.
 Given
   that the patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          Will consider abx if has positive infectious work-up
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, causes anion-gap metabolic acidosis due to increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   Furthermore, her CHILDS-[**Last Name (un) 7720**] classification (which is used in
   patients with cirrhosis to assess peri-operative risk for mortality) is
 given her ascites and serum albumin of 3.4, which puts her at 31%
   risk for dying if she were to have surgery (see Garrison et [**Doctor Last Name **], Annals
   of Surgery [**2108**]). Therefore, at this time the cons of surgery are
   unlikely to out-weight the pros of a new aortic valve.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. We did not get an EKG so we cannot assess fully the rhythm,
   but the outside hospital EKGs suggest junctional rhythm given the lack
   of P waves. This is most likely due to carvedilol
toxicity.
 Given
   that the patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          Will consider abx if has positive infectious work-up
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following potential medical complications can arise:

1. **Infection**: The patient has severe ascites with SBP, which increases the risk of further infections. The patient's WBC count is still elevated, and the differential diagnosis includes aspiration pneumonia, UTI, and other sources of infection.
2. **Renal failure**: The patient has acute on chronic renal failure, which may progress to end-stage renal disease. The patient's creatinine level is 3.5, and the urine output is decreasing. The patient may require dialysis or further management to prevent further kidney damage.
3. **Cardiac complications**: The patient has severe aortic stenosis, which increases the risk of cardiac complications, such as heart failure, arrhythmias, and sudden death. The patient's cardiac biomarkers were negative at the outside hospital, but the patient's cardiac status should be closely monitored.
4. **Gastrointestinal complications**: The patient has a history of gastrointestinal bleeding, and the patient's hematocrit has dropped significantly. The patient should be closely monitored for signs of gastrointestinal bleeding, and the patient's stools should be guaiac tested to check for blood.
5. **Hepatic complications**: The patient has cirrhosis, which increases the risk of hepatic complications, such as encephalopathy, bleeding, and sepsis. The patient's liver function tests are abnormal, and the patient's albumin level is low.
6. **Respiratory complications**: The patient has a history of respiratory problems, and the patient's respiratory status should be closely monitored. The patient's oxygen saturation is 96%, but the patient's respiratory rate is 21 breaths per minute, which may indicate respiratory distress.
7. **Neurological complications**: The patient has a history of neurological problems, and the patient's neurological status should be closely monitored. The patient's mental status is unclear, and the patient's neurological function should be assessed.
8. **Infectious complications**: The patient has a history of infectious complications, including SBP and UTI. The patient should be closely monitored for signs of infection, and the patient's cultures should be checked regularly.

In terms of the patient's current condition, the patient is stable but requires close monitoring for potential complications. The patient's ascites should be closely monitored, and the patient's electrolytes should be repleted as needed. The patient's creatinine level should be trended daily, and the patient's urine output should be closely monitored. The patient's cardiac status should be closely monitored, and the patient's gastrointestinal bleeding should be watched for. The patient's neurological status should be assessed regularly, and the patient's infectious work-up should be completed."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with portal hypertension; total protein ascites 1.7 vs.
   serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
   16:36
   ------ Protected Section ------
   Agree with findings and plan as outline in excellent MS4 note by
   Dryzmalski.
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) 4058**], MD
   on:[**2134-5-23**] 08:06 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with portal hypertension; total protein ascites 1.7 vs.
   serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
   16:36
   ------ Protected Section ------
   Agree with findings and plan as outline in excellent MS4 note by
   Dryzmalski.
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) 4058**], MD
   on:[**2134-5-23**] 08:06 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following potential medical complications can arise:

1. Recurrent Spontaneous Bacterial Peritonitis (SBP): The patient has a high risk of developing recurrent SBP due to her underlying cirrhosis and portal hypertension. A weekly dose of ciprofloxacin is recommended as long-term prophylaxis.
2. Hepatorenal Syndrome (HRS): The patient's acute kidney injury (AKI) may progress to HRS, which is a life-threatening complication of cirrhosis. Close monitoring of her creatinine and urine output is essential.
3. Aortic Stenosis: The patient's aortic stenosis may worsen over time, leading to heart failure, arrhythmias, or even sudden death. Aggressive treatment is not necessary at this time, but the patient will need to be monitored for signs of worsening stenosis.
4. Bradycardia: The patient's bradycardia may persist or worsen due to her underlying cirrhosis and portal hypertension. Close monitoring of her heart rate and rhythm is essential.
5. Acute on Chronic Renal Failure (ACRF): The patient's AKI may worsen over time, leading to chronic kidney disease or even end-stage renal disease.
6. Anemia: The patient's anemia may worsen due to ongoing blood loss, inadequate nutrition, or underlying chronic kidney disease.
7. Hypotension: The patient's hypotension may recur due to her underlying cirrhosis and portal hypertension, as well as her AKI.
8. Gastrointestinal Bleeding: The patient's anemia and ongoing bleeding may worsen over time, leading to life-threatening complications.
9. Infection: The patient's immunosuppressed state and ongoing infection may lead to sepsis or other life-threatening infections.
10. Cardiac Complications: The patient's underlying cardiac disease may worsen over time, leading to heart failure, arrhythmias, or even sudden death.

In summary, the patient is at high risk for multiple complications, including recurrent SBP, HRS, aortic stenosis, bradycardia, ACRF, anemia, hypotension, gastrointestinal bleeding, infection, and cardiac complications. Close monitoring and aggressive treatment are necessary to prevent or manage these complications."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, and ascitic fluid total protein 1.7 vs serum
   total protein 6.5.
   Measurement of the ascetic fluid total protein concentration assists in
   differentiating SBP from secondary bacterial peritonitis, where lowest
   protein concentration correlates with a highest risk of developing SBP
   because of low concentrations of opsonins.
   most consistent with spontaneous bacterial peritonitis (SBP).
   (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   The patient was started on ceftriaxone 1g IV daily x5 days (day
   1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin 1.0g/kg on day 3
   ([**2134-5-23**]). Afterwards, she will need to regular cipro for the rest of
   her life to prevent recurrence.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   Because the vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis, it is most likely that cirrhosis is the cause
   in our patient.
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7713**]
   2. [**URL 7713**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s, and ascitic fluid total protein 1.7 vs serum
   total protein 6.5.
   Measurement of the ascetic fluid total protein concentration assists in
   differentiating SBP from secondary bacterial peritonitis, where lowest
   protein concentration correlates with a highest risk of developing SBP
   because of low concentrations of opsonins.
   most consistent with spontaneous bacterial peritonitis (SBP).
   (
   Low-protein-concentration ascitic fluid is predisposed to spontaneous
   bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Gastroenterology [**2110**] [**Month (only) **];91(6):1343-6.
   TI
   Patients with deficient ascitic fluid opsonic activity are predisposed
   to spontaneous bacterial peritonitis.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7710**] BA
   SO
   Hepatology [**2112**] [**Month (only) 51**]-[**Month (only) **];8(3):632-5.
   )
   The patient was started on ceftriaxone 1g IV daily x5 days (day
   1=[**2134-5-21**]) and albumin 1.5g/kg. She will need albumin 1.0g/kg on day 3
   ([**2134-5-23**]). Afterwards, she will need to regular cipro for the rest of
   her life to prevent recurrence.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   Because the vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis, it is most likely that cirrhosis is the cause
   in our patient.
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([1]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[2]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**URL 7713**]
   2. [**URL 7713**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, I summarize the patient's health progress in the ICU as follows:

The patient is a 77-year-old female with a history of CAD s/p triple CABG, cirrhosis, DMII, HTN, and CRI. She was transferred from another hospital with new findings of severe AS, bradycardia, hypotension, leukocytosis, and ARF. She has a high gradient SAAG (serum albumin - peritoneal fluid albumin) consistent with transudate, and her ascites is likely due to portal hypertension secondary to cirrhosis.

The patient's current condition includes:

1. Severe AS with a valve area of 0.9 cm2, mild LVH, and preserved EF.
2. Bradycardia with a heart rate of 51 bpm, and hypotension requiring initiation of dopamine.
3. Leukocytosis with a WBC count of 19.0, and a differential count showing 91.2% neutrophils.
4. Acute on chronic renal failure with a creatinine level of 3.3 mg/dL.
5. Ascites with a total protein concentration of 1.7 g/dL, and a serum-ascites albumin gradient of 2.3 g/dL.
6. Right shoulder pain, which has been managed with Tylenol.
7. Fever, which is likely due to SBP.

The patient's laboratory results show:

1. WBC count: 19.0
2. Hct: 32.6
3. Plt: 172
4. Cr: 3.3
5. Glucose: 160
6. Albumin: 3.7 g/dL
7. LDH: 141 IU/L
8. Ca++: 8.2 mg/dL
9. Mg++: 2.1 mg/dL
10. PO4: 5.0 mg/dL

The patient's treatment plan includes:

1. Ceftriaxone 1g IV daily x5 days for SBP.
2. Albumin 1.5g/kg for ascites.
3. Dopamine to manage hypotension.
4. Furosemide to manage ascites.
5. TTE to evaluate valve function and severity of AS.
6. EP consultation for pacemaker placement.
7. Hold beta-blocker and calcium-channel blocker due to bradycardia.
8. Monitor on telemetry.

Potential medical complications that can arise from the patient's condition include:

1. Worsening of AS, leading to cardiac failure.
2. Development of cardiac arrhythmias, such as atrial fibrillation.
3. Progression of liver disease, leading to further decompensation of cirrhosis.
4. Renal failure, leading to further deterioration of renal function.
5. Sepsis, leading to multi-organ failure.
6. Pulmonary edema, leading to respiratory failure.
7. Gastrointestinal bleeding, leading to further complications.

The patient's code status is full code, and discussions regarding code status are ongoing. The patient's disposition is currently in the CCU, and further management will depend on the patient's response to treatment and the progression of her condition."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES.
   The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably related to the
   ascites in two ways: (a) via a restrictive process where it is harder
   for her to inhale due to the pressure against her lungs and chest wall;
   and (b) via SBP, which increases her white count, causing anion-gap
   metabolic acidosis due to increased CO2 production, causing tachypnea
   to blow off excess CO2, causing discomfort of breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s (absolute ~2600 polys) and ascitic fluid total
   protein (AFTP) 1.7. The high number of polys (>250) with low AFTP
   (<2.5) suggests SBP. It is the measurement of the ascetic fluid total
   protein concentration that assists in differentiating SBP from
   secondary bacterial peritonitis, because lowest protein concentration
   correlates with the highest risk of developing SBP. It is thought that
   the low protein concentration correlates with low concentrations of
   opsonins, which decreases the efficacy of innate immunity in the
   peritoneum and thus predisposes to infection (see [**Last Name (un) 7710**],
   Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know that most
   cases of SBP are due to gut bacteria (E. coli, Klebsiella) and that
   sometimes even streptococcus and infrequently staphylococcus can be the
   culprit, so treatment with somewhat broad-spectrum antibiotics is
   warranted at least initially. Therefore, our patient was started on
   ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]). Furthermore, patients
   with cirrhosis and SBP frequently have impaired renal function, which
   often results in increased morbidity and mortality. By administering IV
   albumin (which expands plasma volume and increases blood flow to the
   kidneys), one reduces morality rates at three months from 41% to 22%
   (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore, our patient was also given
   albumin 1.5g/kg yesterday, and will receive an additional 1.0g/kg on
   day 3 ([**2134-5-23**]). In terms of long-term prophylaxis, the patient will
   require a weekly dose of 750 mg ciprofloxacin for the rest of her life
   because it decreases incidence of SBP from 22% to 3.6% (see Rolachon et
   [**Doctor Last Name **], Hepatology [**2119**]).
   The etiology of her cirrhosis, on the other hand, is much more
   mysterious. The two most common causes in the USA are alcohol and
   Hepatitis C, and nonalcoholic steatohepatitis is also common.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   In our patient, cirrhosis is the most likely etiology because the vast
   majority of patients with SBP have portal hypertension secondary to
   cirrhosis. Furthermore, CHF is an unlikely cause given her low AFTP
   (CHF is associated with high AFTP), and
   , especially since she does not have have a history of alcohol abuse.
   it is most likely that cirrhosis is the cause in our patient.
   In terms of diagnosis of ascites, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   ascetic fluid total protein concentration, not just the albumin.
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES.
   The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably related to the
   ascites in two ways: (a) via a restrictive process where it is harder
   for her to inhale due to the pressure against her lungs and chest wall;
   and (b) via SBP, which increases her white count, causing anion-gap
   metabolic acidosis due to increased CO2 production, causing tachypnea
   to blow off excess CO2, causing discomfort of breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s (absolute ~2600 polys) and ascitic fluid total
   protein (AFTP) 1.7. The high number of polys (>250) with low AFTP
   (<2.5) suggests SBP. It is the measurement of the ascetic fluid total
   protein concentration that assists in differentiating SBP from
   secondary bacterial peritonitis, because lowest protein concentration
   correlates with the highest risk of developing SBP. It is thought that
   the low protein concentration correlates with low concentrations of
   opsonins, which decreases the efficacy of innate immunity in the
   peritoneum and thus predisposes to infection (see [**Last Name (un) 7710**],
   Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know that most
   cases of SBP are due to gut bacteria (E. coli, Klebsiella) and that
   sometimes even streptococcus and infrequently staphylococcus can be the
   culprit, so treatment with somewhat broad-spectrum antibiotics is
   warranted at least initially. Therefore, our patient was started on
   ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]). Furthermore, patients
   with cirrhosis and SBP frequently have impaired renal function, which
   often results in increased morbidity and mortality. By administering IV
   albumin (which expands plasma volume and increases blood flow to the
   kidneys), one reduces morality rates at three months from 41% to 22%
   (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore, our patient was also given
   albumin 1.5g/kg yesterday, and will receive an additional 1.0g/kg on
   day 3 ([**2134-5-23**]). In terms of long-term prophylaxis, the patient will
   require a weekly dose of 750 mg ciprofloxacin for the rest of her life
   because it decreases incidence of SBP from 22% to 3.6% (see Rolachon et
   [**Doctor Last Name **], Hepatology [**2119**]).
   The etiology of her cirrhosis, on the other hand, is much more
   mysterious. The two most common causes in the USA are alcohol and
   Hepatitis C, and nonalcoholic steatohepatitis is also common.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   In our patient, cirrhosis is the most likely etiology because the vast
   majority of patients with SBP have portal hypertension secondary to
   cirrhosis. Furthermore, CHF is an unlikely cause given her low AFTP
   (CHF is associated with high AFTP), and
   , especially since she does not have have a history of alcohol abuse.
   it is most likely that cirrhosis is the cause in our patient.
   In terms of diagnosis of ascites, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   ascetic fluid total protein concentration, not just the albumin.
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 77-year-old female with a complex medical history, including coronary artery disease, triple CABG, cirrhosis, type II diabetes, hypertension, and chronic kidney disease. She was admitted to the ICU with new findings of severe aortic stenosis, bradycardia, hypotension, and acute on chronic renal failure.

The patient's abdominal girth is increasing due to peritoneal ascites, which is likely secondary to spontaneous bacterial peritonitis (SBP). The diagnosis of SBP is supported by the high white blood cell count in the ascitic fluid and the low ascitic fluid total protein concentration.

The patient's laboratory results show:

* WBC: 19.0
* Hct: 32.6
* Plt: 172
* Cr: 3.3
* Glucose: 160
* Albumin: 3.7 g/dL
* LDH: 141 IU/L
* Ca++: 8.2 mg/dL
* Mg++: 2.1 mg/dL
* PO4: 5.0 mg/dL

The patient's medications include:

* Aspirin 325mg PO daily
* Simvastatin 20mg PO daily
* Furosemide (hold due to renal function)
* Dopamine (weaning)
* Beta-blocker (hold due to bradycardia)
* Calcium-channel blocker (hold due to bradycardia)
* Atropine (at bedside)
* Heparin SC TID (prophylaxis)

The patient's vital signs are:

* Tmax: 37.4°C (99.3°F)
* Tcurrent: 37.2°C (98.9°F)
* HR: 51 (44-65) bpm
* BP: 113/46 (63) mmHg
* RR: 21 (16-29) inspirations per minute
* SpO2: 96%

The patient's physical examination is significant for:

* Mild erythema at nasal bridge, cheeks
* No palmar erythema or spider angiomata
* No caput
* Normal sclera
* EOMI
* Conjunctiva pale
* Supple neck
* No appreciable JVD
* RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest at LUSB
* Diffuse expiratory wheezes; no crackles or rhonchi appreciated
* Obese; visible hernia below right breast; periumbilical; soft, nontender
* Dull to percussion, unable to appreciate fluid wave

The patient's assessment and plan include:

* Continue antibiotics for SBP
* Administer albumin 1.5g/kg to reduce mortality rates
* Monitor for signs of sepsis
* Evaluate for diastolic dysfunction and severity of AS
* Consider intervention for severe AS
* Monitor for signs of AV block and consider pacemaker placement
* Wean dopamine and hold antihypertensives
* Continue to monitor for signs of renal failure and adjust diuretic therapy accordingly
* Continue to monitor for signs of infection and adjust antibiotic therapy accordingly
* Monitor for signs of liver failure and adjust therapy accordingly

Potential medical complications that can arise include:

* Sepsis
* Respiratory failure
* Cardiac failure
* Renal failure
* Liver failure
* Ascites
* Aortic stenosis
* AV block
* Bradycardia
* Hypotension
* Leukocytosis
* Anemia
* Hypocalcemia
* Hypomagnesemia
* Hypophosphatemia

It is essential to closely monitor the patient's vital signs, laboratory results, and physical examination to prevent and manage these potential complications."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s (absolute ~2600 polys) and ascitic fluid total
   protein (AFTP) 1.7. The high number of polys (>250) with low AFTP
   (<2.5) suggests SBP. It is the measurement of the ascetic fluid total
   protein concentration that assists in differentiating SBP from
   secondary bacterial peritonitis, because lowest protein concentration
   correlates with the highest risk of developing SBP. It is thought that
   the low protein concentration correlates with low concentrations of
   opsonins, which decreases the efficacy of innate immunity in the
   peritoneum and thus predisposes to infection (see [**Last Name (un) 7710**],
   Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know that most
   cases of SBP are due to gut bacteria (E. coli, Klebsiella) and that
   sometimes even streptococcus and infrequently staphylococcus can be the
   culprit, so treatment with somewhat broad-spectrum antibiotics is
   warranted at least initially. Therefore, our patient was started on
   ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]). Furthermore, patients
   with cirrhosis and SBP frequently have impaired renal function, which
   often results in increased morbidity and mortality. By administering IV
   albumin (which expands plasma volume and increases blood flow to the
   kidneys), one reduces morality rates at three months from 41% to 22%
   (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore, our patient was also given
   albumin 1.5g/kg yesterday, and will receive an additional 1.0g/kg on
   day 3 ([**2134-5-23**]). In terms of long-term prophylaxis, the patient will
   require a weekly dose of 750 mg ciprofloxacin for the rest of her life
   because it decreases incidence of SBP from 22% to 3.6%, without
   development of acquired resistance to ciprofloxacin (see Rolachon et
   [**Doctor Last Name **], Hepatology [**2119**]).
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   In our patient, cirrhosis is the most likely etiology because the vast
   majority of patients with SBP have portal hypertension secondary to
   cirrhosis. Furthermore, CHF is an unlikely cause given her low AFTP
   (CHF is associated with high AFTP), and
   , especially since she does not have have a history of alcohol abuse.
   it is most likely that cirrhosis is the cause in our patient.
   In terms of diagnosis of ascites, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   ascetic fluid total protein concentration, not just the albumin.
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s (absolute ~2600 polys) and ascitic fluid total
   protein (AFTP) 1.7. The high number of polys (>250) with low AFTP
   (<2.5) suggests SBP. It is the measurement of the ascetic fluid total
   protein concentration that assists in differentiating SBP from
   secondary bacterial peritonitis, because lowest protein concentration
   correlates with the highest risk of developing SBP. It is thought that
   the low protein concentration correlates with low concentrations of
   opsonins, which decreases the efficacy of innate immunity in the
   peritoneum and thus predisposes to infection (see [**Last Name (un) 7710**],
   Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know that most
   cases of SBP are due to gut bacteria (E. coli, Klebsiella) and that
   sometimes even streptococcus and infrequently staphylococcus can be the
   culprit, so treatment with somewhat broad-spectrum antibiotics is
   warranted at least initially. Therefore, our patient was started on
   ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]). Furthermore, patients
   with cirrhosis and SBP frequently have impaired renal function, which
   often results in increased morbidity and mortality. By administering IV
   albumin (which expands plasma volume and increases blood flow to the
   kidneys), one reduces morality rates at three months from 41% to 22%
   (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore, our patient was also given
   albumin 1.5g/kg yesterday, and will receive an additional 1.0g/kg on
   day 3 ([**2134-5-23**]). In terms of long-term prophylaxis, the patient will
   require a weekly dose of 750 mg ciprofloxacin for the rest of her life
   because it decreases incidence of SBP from 22% to 3.6%, without
   development of acquired resistance to ciprofloxacin (see Rolachon et
   [**Doctor Last Name **], Hepatology [**2119**]).
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   In our patient, cirrhosis is the most likely etiology because the vast
   majority of patients with SBP have portal hypertension secondary to
   cirrhosis. Furthermore, CHF is an unlikely cause given her low AFTP
   (CHF is associated with high AFTP), and
   , especially since she does not have have a history of alcohol abuse.
   it is most likely that cirrhosis is the cause in our patient.
   In terms of diagnosis of ascites, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   ascetic fluid total protein concentration, not just the albumin.
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 77-year-old female with a history of coronary artery disease, cirrhosis, type II diabetes, and hypertension, who was transferred to the ICU from another hospital with new findings of severe aortic stenosis, bradycardia, hypotension, leukocytosis, and acute on chronic renal failure. She has been diagnosed with spontaneous bacterial peritonitis (SBP) and has undergone ultrasound-guided paracentesis, which removed 1.4L of peritoneal fluid. She has been started on ceftriaxone and albumin to treat SBP and ascites.

Potential Medical Complications:

1. Cardiac complications:
	* Aortic stenosis may worsen due to increased cardiac output and decreased cardiac function.
	* Bradycardia and hypotension may indicate decreased cardiac output and increased risk of cardiac arrest.
	* Consideration for pacemaker placement or valve replacement may be necessary.
2. Renal complications:
	* Acute on chronic renal failure may worsen due to decreased cardiac output, hypotension, and potential prerenal etiology.
	* Consideration for dialysis may be necessary if renal function continues to decline.
3. Respiratory complications:
	* Ascites may worsen respiratory function due to increased pressure on the lungs and chest wall.
	* Consideration for non-invasive ventilation or mechanical ventilation may be necessary.
4. Infectious complications:
	* SBP may lead to sepsis and multi-organ failure if not properly treated.
	* Consideration for broad-spectrum antibiotics and antifungal therapy may be necessary.
5. Gastrointestinal complications:
	* Ascites may lead to gastrointestinal bleeding or perforation if not properly managed.
	* Consideration for endoscopic or surgical management of ascites may be necessary.
6. Neurological complications:
	* Leukocytosis may indicate increased risk of neurological complications, such as sepsis-induced encephalopathy or meningitis.
	* Consideration for neurological consultation and monitoring may be necessary.

Overall, the patient's condition is complex and requires close monitoring and management to prevent potential complications."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s (absolute ~2600 polys) and ascitic fluid total
   protein (AFTP) 1.7. The high number of polys (>250) with low AFTP
   (<2.5) suggests SBP. It is the measurement of the ascetic fluid total
   protein concentration that assists in differentiating SBP from
   secondary bacterial peritonitis, because lowest protein concentration
   correlates with the highest risk of developing SBP. It is thought that
   the low protein concentration correlates with low concentrations of
   opsonins, which decreases the efficacy of innate immunity in the
   peritoneum and thus predisposes to infection (see [**Last Name (un) 7710**],
   Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know that most
   cases of SBP are due to [**Male First Name (un) **] bacteria (E. coli, Klebsiella) and that
   sometimes even streptococcus and infrequently staphylococcus can be the
   culprit. Therefore, treatment with somewhat broad-spectrum antibiotics
   is warranted unless further susceptibility can be found. Therefore, our
   patient was started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   She was also started on albumin 1.5g/kg, because
. (look this up)
   She will need albumin 1.0g/kg on day 3 ([**2134-5-23**]). Afterwards, she will
   need to continue regular cipro for the rest of her life to prevent
   recurrence.
   In terms of long-term prophylaxis, there was astudy (below
   single weekly dose of 750 mg of [1]ciprofloxacin [[2]32]. In this
   trial, 60 patients with cirrhosis and a low ascitic fluid protein
   concentration (
1.5 g/dL) were randomly assigned to weekly
   ciprofloxacin or placebo for six months. There was a significant
   decrease in the incidence of SBP with ciprofloxacin (3.6 versus 22
   percent) without the development of acquired resistance to
   ciprofloxacin.
   Ciprofloxacin and long-term prevention of spontaneous bacterial
   peritonitis: results of a prospective controlled trial.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7713**] A; [**Last Name (un) 7714**] L; Bacq Y; Nousbaum JB; [**Last Name (un) 7715**] A; [**First Name8 (NamePattern2) 7697**] [**Last Name (NamePattern1) 561**]; Fratte
   S; [**Last Name (un) 7716**] B; Kitmacher P; [**Last Name (un) 7717**] JP; et [**Doctor Last Name **].
   SO
   Hepatology [**2119**] [**Month (only) **];22(4 Pt 1):1171-4.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   Because the vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis, it is most likely that cirrhosis is the cause
   in our patient.
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([3]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[4]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**Numeric Identifier 7718**]
   2. [**URL 7719**]
   3. [**URL 7720**]
   4. [**URL 7720**]
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # ASCITES. The patient
s increasing abdominal girth is due to
   increasing peritoneal ascites. Her shortness of breath was probably
   related to the ascites in two ways: (a) via a restrictive process where
   it is harder for her to inhale due to the pressure against her lungs
   and chest wall; and (b) via SBP, which increases her white count,
   causing anion-gap metabolic acidosis due to increased CO2 production,
   causing tachypnea to blow off excess CO2, causing discomfort of
   breathing.
   Yesterday
s ultrasound-guided paracentesis showed ~5L of ascites.
   Approximately 1.4L of peritoneal fluid was removed and showed WBC of
   >2900 with 92% poly
s (absolute ~2600 polys) and ascitic fluid total
   protein (AFTP) 1.7. The high number of polys (>250) with low AFTP
   (<2.5) suggests SBP. It is the measurement of the ascetic fluid total
   protein concentration that assists in differentiating SBP from
   secondary bacterial peritonitis, because lowest protein concentration
   correlates with the highest risk of developing SBP. It is thought that
   the low protein concentration correlates with low concentrations of
   opsonins, which decreases the efficacy of innate immunity in the
   peritoneum and thus predisposes to infection (see [**Last Name (un) 7710**],
   Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know that most
   cases of SBP are due to [**Male First Name (un) **] bacteria (E. coli, Klebsiella) and that
   sometimes even streptococcus and infrequently staphylococcus can be the
   culprit. Therefore, treatment with somewhat broad-spectrum antibiotics
   is warranted unless further susceptibility can be found. Therefore, our
   patient was started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   She was also started on albumin 1.5g/kg, because
. (look this up)
   She will need albumin 1.0g/kg on day 3 ([**2134-5-23**]). Afterwards, she will
   need to continue regular cipro for the rest of her life to prevent
   recurrence.
   In terms of long-term prophylaxis, there was astudy (below
   single weekly dose of 750 mg of [1]ciprofloxacin [[2]32]. In this
   trial, 60 patients with cirrhosis and a low ascitic fluid protein
   concentration (
1.5 g/dL) were randomly assigned to weekly
   ciprofloxacin or placebo for six months. There was a significant
   decrease in the incidence of SBP with ciprofloxacin (3.6 versus 22
   percent) without the development of acquired resistance to
   ciprofloxacin.
   Ciprofloxacin and long-term prevention of spontaneous bacterial
   peritonitis: results of a prospective controlled trial.
   [**Name Prefix (Prefixes) **]
   [**Last Name (Prefixes) 7713**] A; [**Last Name (un) 7714**] L; Bacq Y; Nousbaum JB; [**Last Name (un) 7715**] A; [**First Name8 (NamePattern2) 7697**] [**Last Name (NamePattern1) 561**]; Fratte
   S; [**Last Name (un) 7716**] B; Kitmacher P; [**Last Name (un) 7717**] JP; et [**Doctor Last Name **].
   SO
   Hepatology [**2119**] [**Month (only) **];22(4 Pt 1):1171-4.
   The etiology of her ascites is portal hypertension as evidenced by her
   high gradient SAAG (serum albumin - peritoneal fluid albumin = 3.4-1.1
   = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **]. in Annals of Internal
   Medicine [**2116**]]). In general, top of the differential diagnosis for
   portal hypertension includes cirrhosis, CHF, and alcoholic hepatitis.
   Because the vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis, it is most likely that cirrhosis is the cause
   in our patient.
    AFTP of most spontaneously infected ascites is usually low,
   The vast majority of patients with SBP have portal hypertension
   secondary to cirrhosis. Patients with a serum-ascites albumin gradient
   below 1.1 g/dL (ie, without portal hypertension) rarely develop SBP.
   Measurement of the ascitic fluid total protein concentration assists in
   separating SBP from secondary bacterial peritonitis ([3]see
   ""Distinction of spontaneous from secondary bacterial peritonitis""
   below). It correlates inversely with the risk of developing SBP
   [[4]15]. Patients with the most dilute ascites (ie, protein
   concentration less than 1 gm/dL) have the lowest concentration of
   opsonins in the ascitic fluid and are at the highest risk for SBP
   Please note that high vs. low gradient SAAG is not the same as
   transudative/exudative ascites, which refers specifically to ascetic
   fluid total protein concentration, not just the albumin.
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS and recent episodes of
   bradycardia, hypotension. History also significant for leukocytosis,
   acute on chronic renal failure.
   .
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed above. No chest pain
   currently or prior to OSH admission, although this is not necessarily
   reassuring in this female, diabetic patient. By report, cardiac
   biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - TTE to evaluate for diastolic dysfunction, severity of AS
   - Hold beta-blocker given recent bradycardia, hypotension. Hold
   hypotension given recent hypotension; unclear if patient needs to be on
   ACE inhibitor as she is not known to have heart failure.
   - Will restart furosemide as renal function improves
   .
   #. Aortic stenosis:  Reported as severe at OSH with valve area 0.7,
   peak gradient 100mgHg. Interestingly, patient has had TTE in past
   (records unavailable at this time) without mention of aortic stenosis.
   Aortic stenosis likely contributes to this patient's dyspnea.
   - TTE to evaluate valve function
   - If severe, consider intervention. Valvuloplasty would be a temporary
   solution. AVR is more permanent, but given cirrhosis, risk of surgery
   may be high.
   .
   # RHYTHM:  Bradycardic to mid-30s at OSH. EKG with junctional rhythm.
   Could this have been in context of decreased clearance of beta-blocker?
   Currently in NSR with rate in 60s. No evidence of AV block. No ischemic
   changes seen in RCA territory to suggest sinus node dysfunction.
   - EP consulted for evaluation for pacemaker placement
   - Hold beta-blocker, calcium-channel blocker
   - Atropine at bedside
   - Monitor on telemetry
   .
   #. Hypotension:  Noted with onset of bradycardia. Transferred on
   dopamine at 5mcg/kg/min. Patient with hypertension at baseline. Appears
   to be cardiogenic in origin given bradycardia; it is unclear whether
   attempt was made to wean patient off of dopamine once bradycardia
   resolved. Given leukocytosis, sepsis is also on differential.
   - Continue to wean dopamine
   - Hold antihypertensives
   - Will cater antibiotics (if needed) based on infectious work-up below
   .
   # h/o liver cirrhosis:  Underlying etiology unknown. Followed by Dr.
   [**First Name (STitle) 2578**] at [**Hospital1 19**]. Previously attributed to steatohepatitis. Complicated by
   portal hypertension, ascites. MELD 24, CHILDS B.
   - Abdominal ultrasound with doppler
   - Ultrasound-guided paracentesis (diagnostic)
   - Liver recs (Dr. [**First Name (STitle) 2578**]
   - Low salt diet, fluid restriction
   .
   #. Leukocytosis:  No clear source of infection. Differential diagnosis
   includes aspiration pneumonia, SBP, UTI. Was given levofloxacin IV at
   OSH given suspicion for aspiration pneumonia.
   - CXR
   - UA
   - Urine culture, blood cultures
   - Diagnostic paracentesis
   .
   #. Acute on chronic renal failure:  Baseline 1.7. Creatinine now 3.3.
   Differential includes ATN secondary to respond hypotensive episode
   (although patient was with renal failure prior to episode yesterday),
   prerenal etiology given poor cardiac output secondary to aortic
   stenosis. [**Month (only) 51**] also be secondary to medications - recently started on
   HCTZ.
   - Urine lytes, UA
   - Close monitoring of urine output
   - Hold diuretics
   .
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet; fluid restriction 1.5L;
   replete lytes as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Discussions regarding code status are ongoing.
   DISPO: CCU for now
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
References
   1. [**Numeric Identifier 7718**]
   2. [**URL 7719**]
   3. [**URL 7720**]
   4. [**URL 7720**]<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications are potential:

1. Spontaneous Bacterial Peritonitis (SBP): The patient's ascites fluid has a high WBC count (>2900) with 92% polymorphonuclear cells, suggesting SBP. The patient has been treated with ceftriaxone, and albumin will be continued to help resolve the ascites.
2. Acute Renal Failure (ARF): The patient's creatinine level has increased from 1.7 to 3.3, indicating ARF. The differential diagnosis includes ATN secondary to hypotensive episode, prerenal etiology due to poor cardiac output secondary to aortic stenosis, and medications such as HCTZ.
3. Hypotension: The patient's blood pressure is low, and the patient is receiving dopamine to support blood pressure. The hypotension is likely cardiogenic in origin, given the patient's bradycardia.
4. Aortic Stenosis: The patient has severe aortic stenosis, which is contributing to the patient's dyspnea. The patient may require intervention, such as valvuloplasty or AVR.
5. Bradycardia: The patient's heart rate is slow, and the patient is at risk for sinus node dysfunction.
6. Leukocytosis: The patient's WBC count is elevated, and the differential diagnosis includes aspiration pneumonia, SBP, and UTI.
7. Portal Hypertension: The patient has portal hypertension, which is contributing to the ascites.
8. Cirrhosis: The patient has cirrhosis, which is the underlying etiology of the portal hypertension and ascites.
9. Respiratory Failure: The patient's shortness of breath is likely related to the ascites and aortic stenosis.
10. Infection: The patient has a high risk of developing infection due to the ascites and the use of antibiotics.

The patient's treatment plan includes:

* Continued treatment for SBP with ceftriaxone and albumin
* Management of ARF with close monitoring of urine output and consideration of diuretic therapy
* Supportive care for hypotension with dopamine and consideration of weaning
* Intervention for aortic stenosis, including valvuloplasty or AVR
* Monitoring for bradycardia and consideration of pacemaker placement
* Evaluation for infection with CXR, UA, urine culture, and blood cultures
* Management of portal hypertension with abdominal ultrasound and doppler
* Monitoring for cirrhosis with liver function tests and consideration of liver transplantation
* Supportive care for respiratory failure with oxygen therapy and consideration of mechanical ventilation
* Prophylaxis for DVT, stress ulcer, and VAP."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///16/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///16/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 61-year-old individual admitted to the ICU with a chief complaint of ascites. Over the past 24 hours, the patient underwent ultrasound-guided paracentesis, removing 1.4L of peritoneal fluid consistent with spontaneous bacterial peritonitis (SBP). The patient is being treated with ceftriaxone for 5 days and albumin 1.5g/kg. The patient's liver function is compromised, with elevated liver enzymes and bilirubin. The patient also has aortic stenosis, mild left ventricular hypertrophy, and pulmonary artery systolic hypertension. The patient is experiencing right shoulder pain and has a history of allergies to amoxicillin, sulfa, and iodine. The patient's vital signs are stable, with a temperature of 37.2°C, heart rate of 51bpm, and blood pressure of 113/46mmHg.

Potential medical complications:

1. Worsening of ascites: The patient's ascites may continue to worsen if the underlying liver disease is not addressed.
2. Bacterial peritonitis: The patient's SBP may lead to further complications, such as sepsis, if not effectively treated.
3. Renal failure: The patient's creatinine level is elevated, indicating potential renal failure, which may worsen if not managed properly.
4. Hypoglycemia: The patient's glucose level is elevated, which may indicate potential hypoglycemia if not managed properly.
5. Aortic stenosis: The patient's aortic stenosis may lead to further complications, such as heart failure, if not managed properly.
6. Pulmonary hypertension: The patient's pulmonary hypertension may lead to further complications, such as right heart failure, if not managed properly.
7. Hepatorenal syndrome: The patient's elevated bilirubin and liver enzymes may indicate potential hepatorenal syndrome, which may worsen if not managed properly.
8. Infection: The patient's history of allergies and recent antibiotics may indicate potential infection, which should be monitored and treated promptly if necessary.
9. Nutritional deficiencies: The patient's ascites and liver disease may lead to nutritional deficiencies, which should be monitored and addressed if necessary.
10. Respiratory complications: The patient's respiratory status may deteriorate if not properly managed, particularly with the presence of ascites and potential pulmonary hypertension."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///16/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: ///16/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 61-inch tall individual admitted to the ICU with a chief complaint of unknown. The patient has a history of allergies to amoxicillin, sulfa, and iodine. The patient has received ceftriaxone antibiotics, with the last dose administered at 08:12 PM on [**2134-5-21**].

The patient's vital signs are as follows:

* Temperature: 37.4°C (99.3°F) with a current temperature of 37.2°C (98.9°F)
* Heart rate: 51 beats per minute (bpm) with a range of 44-65 bpm
* Blood pressure: 113/46 mmHg with a range of 92-125/81 mmHg mmHg
* Respiratory rate: 21 inspirations per minute (insp/min) with a range of 16-29 insp/min
* Oxygen saturation: 96%
* Heart rhythm: sinus bradycardia

The patient has a fluid balance of 1,389 mL in and 2,062 mL out, resulting in a negative balance of 673 mL. The patient has received blood products totaling 235 mL and 165 mL, and has a total output of 347 mL of urine.

The patient's laboratory results include:

* White blood cell count: 19.0 K/uL
* Hemoglobin: 8.8 g/dL
* Platelet count: 172
* Creatinine: 3.3 mg/dL
* Blood urea nitrogen: 133 mg/dL
* Glucose: 160 mg/dL
* Other laboratory results include abnormal liver function tests, elevated lactate dehydrogenase, and abnormal electrolyte levels.

The patient's physical examination is limited due to the patient's inability to assess certain vital signs and body systems.

The patient's assessment and plan include:

* PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
* RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
* DIABETES MELLITUS (DM), TYPE II
* AORTIC STENOSIS
* ASCITES
* KNOWLEDGE DEFICIT

Potential medical complications that can arise from this patient's conditions include:

* Worsening of acute renal failure, potentially leading to chronic kidney disease or end-stage renal disease
* Hyperglycemia and potential development of diabetic ketoacidosis
* Increased risk of cardiovascular events due to aortic stenosis
* Potential complications from ascites, such as infection or rupture
* Knowledge deficit and potential for medication errors or non-adherence to treatment plan
* Potential for further deterioration in physical condition due to underlying medical conditions."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with transudate; total protein ascites 1.7 vs. serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 61-year-old male admitted to the ICU with a diagnosis of acute liver failure, acute kidney injury, and ascites. He underwent ultrasound-guided paracentesis, removing 1.4L of peritoneal fluid consistent with spontaneous bacterial peritonitis (SBP). He is receiving ceftriaxone and albumin infusions. His laboratory results show elevated bilirubin, alkaline phosphatase, and liver enzymes, indicating ongoing liver damage. He has also developed acute kidney injury, with a creatinine level of 3.5mg/dL. He is experiencing right shoulder pain and has a known allergy to amoxicillin and sulfa.

Potential Medical Complications:

1. Infection: The patient is at risk of developing secondary infections due to his immunocompromised state and the presence of ascites.
2. Renal Failure: The patient's acute kidney injury may progress to chronic kidney disease if not managed properly.
3. Liver Failure: The patient's ongoing liver damage may lead to further deterioration of his liver function, potentially resulting in liver failure.
4. Respiratory Failure: The patient's ascites and potential respiratory complications may lead to respiratory failure.
5. Sepsis: The patient's SBP and potential secondary infections may lead to sepsis, which can be life-threatening.
6. Cardiovascular Complications: The patient's aortic stenosis and hypertension may increase his risk of cardiovascular complications, such as heart failure or arrhythmias.
7. Nutritional Deficiencies: The patient's malnutrition and potential gastrointestinal complications may lead to deficiencies in essential nutrients.
8. Wound Complications: The patient's ascites and potential surgical interventions may increase his risk of developing wound complications, such as infections or dehiscence.

These potential complications highlight the importance of close monitoring and management of the patient's condition in the ICU."
158518.0,285503,2134-05-22 07:17:00,Physician ,Physician Resident Progress Note,"TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with portal hypertension; total protein ascites 1.7 vs.
   serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
   16:36
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE: SUB-INTERN PROGRESS NOTE
   24 Hour Events:
   - Ultrasound-guided paracentesis (1.4L removed); peritoneal fluid
   consistent with SBP; ceftriaxone 1g IV daily x5 days, albumin 1.5g/kg
   - SAAG = serum albumin - peritoneal fluid albumin = 3.4-1.1 = 2.3,
   consistent with portal hypertension; total protein ascites 1.7 vs.
   serum 6.5
   - TTE with AS, valve area 0.9cm2; mild LVH with presernved EF;
   PCWP>18mmHg; 2+ MR; mild pulmonary artery systolic hypertension; no
   pericardial effusion
   - UA with blood, mod leuk est, 35 WBC; Foley removed
   - RUQ duplex u/s:  Normal Doppler patency and flow of the hepatic
   veins, portal vein
   - Fe urea nitrogen 27.5%, urine sodium 20; prerenal, does not exclude
   hepatorenal
   - Right shoulder pain x1 week; written for Tylenol, 2g maximum
   Allergies:
   Amoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-22**] 07:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.3
   Tcurrent: 37.2
C (98.9
   HR: 51 (44 - 65) bpm
   BP: 113/46(63) {92/21(45) - 125/81(89)} mmHg
   RR: 21 (16 - 29) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Height: 61 Inch
                  Total In:
                                                                  1,389 mL
                                                                    165 mL
   PO:
                                                                    240 mL
                  TF:
   IVF:
                                                                     94 mL
   Blood products:
                                                                    235 mL
                                                                    165 mL
   Total out:
                                                                  2,062 mL
                                                                      0 mL
   Urine:
                                                                    347 mL
   NG:
   Stool:
   Drains:
                                                                  1,400 mL
   Balance:
                                                                   -673 mL
                                                                    165 mL
   Respiratory support
   O2 Delivery Device: ROOM AIR
   SpO2: 96%
   Physical Examination
   GENERAL:  Resting comfortably with head of bed elevated 30 degrees.
   Oriented x3.
   SKIN:  Not jaundiced. Mild erythema at nasal bridge, cheeks. No palmar
   erythema. No spider angiomata. No caput.
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes; no crackles, rhonchi appreciated
   ABDOMEN:  Obese; visible hernia below right breast, periumbilical;
   soft, nontender. Dull to percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   114 K/uL
   8.8 g/dL
   133 mg/dL
   3.5 mg/dL
   16 mEq/L
   4.7 mEq/L
   70 mg/dL
   107 mEq/L
   135 mEq/L
   25.9 %
   9.4 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
   WBC
   19.0
   9.4
   Hct
   32.6
   25.9
   Plt
   172
   114
   Cr
   3.3
   3.5
   Glucose
   160
   133
   Other labs: PT / PTT / INR:18.7/33.3/1.7, ALT / AST:[**12-11**], Alk Phos / T
   Bili:54/0.7, Differential-Neuts:91.2 %, Lymph:6.5 %, Mono:2.2 %,
   Eos:0.1 %, Albumin:3.7 g/dL, LDH:141 IU/L, Ca++:8.2 mg/dL, Mg++:2.1
   mg/dL, PO4:5.0 mg/dL
   Assessment and Plan
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   FEN:  Diabetic, heart healthy, low-salt diet, kidney-friendly (low
   protein), and liver healthy diet; fluid restriction 1.5L; replete lytes
   as needed
   ACCESS:  PIV x2
   PROPHYLAXIS:  Heparin SC TID; pneumoboots; home PPI; bowel regimen
   CONTACT:  [**Name (NI) 1125**] ([**Name2 (NI) 2685**], HCP), ([**Telephone/Fax (1) 7698**]
   CODE:  FULL CODE. Patient wishes to discuss this with family before
   making any other decisions.
   DISPO: CCU for now
   16:36<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 77-year-old female with a complex medical history, including coronary artery disease (CAD) post-triple coronary artery bypass grafting (CABG), cirrhosis, type II diabetes, and hypertension. She was admitted to the intensive care unit (ICU) with new findings of severe aortic stenosis (AS), bradycardia, hypotension, leukocytosis, and acute renal failure (ARF).

The patient's ascites is due to portal hypertension, and the ultrasound-guided paracentesis showed peritoneal fluid with a high number of polymorphonuclear cells (>250) and low ascitic fluid total protein (<2.5), consistent with spontaneous bacterial peritonitis (SBP). She was started on ceftriaxone 1g IV daily x5 days and albumin 1.5g/kg.

The patient's cirrhosis is likely due to nonalcoholic steatohepatitis, but a biopsy is needed to confirm the diagnosis. Her MELD score is 23, which is associated with a high mortality rate.

The patient's acute renal failure is likely due to acute tubular necrosis (ATN) caused by supra-therapeutic effects of carvedilol, which has been discontinued. Her creatinine is 3.5, and she has a good story for other causes of ARF, such as SBP and hypotension. She will be closely monitored for her creatinine levels and urine output.

The patient's anemia is likely due to a gastrointestinal bleed, and she was started on a proton pump inhibitor and a type and screen was sent. She will be guaiac-stained to check for gastrointestinal bleeding.

The patient's hypotension has resolved, and she is no longer on dopamine. Her WBC has dropped to 19, and she has no fever, making septic shock less likely. Her liver disease may play a role in dropping her blood pressure.

The patient's coronary artery disease is stable, and she will continue to receive aspirin, simvastatin, and Humalog.

The patient's diet will be modified to a low-salt, kidney-friendly diet, and she will be replete with electrolytes as needed. She will also receive prophylaxis for deep vein thrombosis and pneumococcal disease.

The patient's code status is full code, and she wishes to discuss this with her family before making any decisions.

The patient's current medications include:

* Ceftriaxone 1g IV daily x5 days
* Albumin 1.5g/kg
* Aspirin 325mg PO daily
* Simvastatin 20mg PO daily
* Humalog sliding scale per home regimen
* Proton pump inhibitor
* Heparin SC TID
* Pneumoboots
* Bowel regimen

The patient's laboratory results include:

* WBC 19.0
* Hct 25.9%
* Plt 172
* Cr 3.5
* Glucose 133
* Albumin 3.7g/dL
* LDH 141 IU/L
* Ca++ 8.2mg/dL
* Mg++ 2.1mg/dL
* PO4 5.0mg/dL

The patient's imaging studies include:

* TTE with severe AS and mild LVH
* Ultrasound-guided paracentesis showing peritoneal fluid with a high number of polymorphonuclear cells (>250) and low ascitic fluid total protein (<2.5)

The patient's plan includes:

* Continue ceftriaxone 1g IV daily x5 days
* Albumin 1.0g/kg on [**2134-5-23**]
* Consider Cipro 750mg qweek after ceftriaxone is discontinued
* Low salt diet and fluid restriction
* Hold diuretics
* Trend creatinine daily
* IV albumin tomorrow
* Nephrology consult
* Urine lytes, UA
* Close monitoring of urine output
* Hold beta-blocker
* Hold calcium-channel blocker
* Atropine at bedside
* Monitor on telemetry
* Guaiac stool
* Hold anti-hypertensives"
158518.0,285503,2134-05-23 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Shock - cardiogenic
   24 Hour Events:
   - Hct drop to 25.9 with am labs. Guaiac neg. Repeat Hct 28.2
   - Fena 0.3
   - Code status confirmed as FULL
   - Renal c/s - More c/w Pre-renal azotemia. Urine sediment with many
   casts more c/w ATN. Less likely HRS given normal BPs and active
   sediment. Added on Urine Eos.
   - Liver c/s - Did not see patient, but suggested midodrine and
   octreotide. Decision deferrred until Liver team can see the patient in
   person
   - EP recs none
   History obtained from Patient
   Allergies:
   History obtained from PatientAmoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2134-5-22**] 10:00 PM
   Heparin Sodium (Prophylaxis) - [**2134-5-22**] 11:19 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-23**] 07:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.7
C (98
   HR: 57 (53 - 60) bpm
   BP: 151/55(77) {102/40(62) - 154/77(90)} mmHg
   RR: 15 (15 - 30) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 77 kg (admission): 79.8 kg
   Height: 61 Inch
                  Total In:
                                                                  1,515 mL
                                                                    260 mL
   PO:
                                                                    840 mL
                                                                    260 mL
   TF:
   IVF:
                                                                    510 mL
   Blood products:
                                                                    165 mL
   Total out:
                                                                    328 mL
                                                                    285 mL
   Urine:
                                                                    328 mL
                                                                    285 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,187 mL
                                                                    -25 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   131 K/uL
   9.2 g/dL
   132 mg/dL
   3.4 mg/dL
   17 mEq/L
   4.5 mEq/L
   79 mg/dL
   108 mEq/L
   134 mEq/L
   27.7 %
   8.2 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
                             [**2134-5-22**]  03:00 PM
                             [**2134-5-23**]  05:42 AM
   WBC
   19.0
   9.4
   8.2
   Hct
   32.6
   25.9
   28.2
   27.7
   Plt
   172
   114
   131
   Cr
   3.3
   3.5
   3.7
   3.4
   Glucose
   160
   133
   140
   132
   Other labs: PT / PTT / INR:16.3/31.2/1.5, ALT / AST:15/18, Alk Phos / T
   Bili:73/0.6, Differential-Neuts:84.6 %, Lymph:11.4 %, Mono:2.6 %,
   Eos:1.1 %, Albumin:3.6 g/dL, LDH:157 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.  Unknown etiology.  On CTX for 5 day
   course.
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg today
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Transfer to liver service now that pt is stable
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  Severe, new dx.
   - CT [**Doctor First Name 213**] c/s for non-emergent intervention
   - cards will continue to follow while on floor
   # BRADYCARDIA.  Down to 50
s while sleeping.
   -          holding anti HTN
   -          EP consult, appreciate recs
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  Cr at 3.4, down from 3.7.  Baseline
   1.7.  Sediment suggestive of ATN given casts, and hypotension at OSH.
   Also consdiered HRS though less likely.   UOP improving over last 24
   hours, 400 since MN.
   - renal following, appreciate recs
   -  Continue trending creatinine [**Last Name (un) **]
   -          IV albumin today
   -          monitor UOP
   -          Hold diuretics
   # ANEMIA.  Stable at 27 this morning.  The patient had a drop in
   hematocrit from 32 to 25 yesterday.  Guaiac neg.  Pt reportedly on
   epogen 10,000u qSaturday.
   - trend daiy
   - will ask renal about why pt on epogen
   # HYPOTENSION:  Resolved.  Likely in setting of SBP.
   -          Hold anti-hypertensives
   -          On ceftriaxone as abov
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - decrease ASA to 81mg
   - Holding anti HTN as above
   - Continue simvastatin 20mg PO daily
   #. PUMP:  EF 65-70%.  AS as above.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   Nutrition:  low salt
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   22 Gauge - [**2134-5-22**] 02:40 PM
   Prophylaxis:
   DVT:  heparin sq
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  FULL
   Disposition: call out to [**Doctor Last Name 976**] [**Doctor Last Name 2578**] service
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Shock - cardiogenic
   24 Hour Events:
   - Hct drop to 25.9 with am labs. Guaiac neg. Repeat Hct 28.2
   - Fena 0.3
   - Code status confirmed as FULL
   - Renal c/s - More c/w Pre-renal azotemia. Urine sediment with many
   casts more c/w ATN. Less likely HRS given normal BPs and active
   sediment. Added on Urine Eos.
   - Liver c/s - Did not see patient, but suggested midodrine and
   octreotide. Decision deferrred until Liver team can see the patient in
   person
   - EP recs none
   History obtained from Patient
   Allergies:
   History obtained from PatientAmoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2134-5-22**] 10:00 PM
   Heparin Sodium (Prophylaxis) - [**2134-5-22**] 11:19 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-23**] 07:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.7
C (98
   HR: 57 (53 - 60) bpm
   BP: 151/55(77) {102/40(62) - 154/77(90)} mmHg
   RR: 15 (15 - 30) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 77 kg (admission): 79.8 kg
   Height: 61 Inch
                  Total In:
                                                                  1,515 mL
                                                                    260 mL
   PO:
                                                                    840 mL
                                                                    260 mL
   TF:
   IVF:
                                                                    510 mL
   Blood products:
                                                                    165 mL
   Total out:
                                                                    328 mL
                                                                    285 mL
   Urine:
                                                                    328 mL
                                                                    285 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,187 mL
                                                                    -25 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   131 K/uL
   9.2 g/dL
   132 mg/dL
   3.4 mg/dL
   17 mEq/L
   4.5 mEq/L
   79 mg/dL
   108 mEq/L
   134 mEq/L
   27.7 %
   8.2 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
                             [**2134-5-22**]  03:00 PM
                             [**2134-5-23**]  05:42 AM
   WBC
   19.0
   9.4
   8.2
   Hct
   32.6
   25.9
   28.2
   27.7
   Plt
   172
   114
   131
   Cr
   3.3
   3.5
   3.7
   3.4
   Glucose
   160
   133
   140
   132
   Other labs: PT / PTT / INR:16.3/31.2/1.5, ALT / AST:15/18, Alk Phos / T
   Bili:73/0.6, Differential-Neuts:84.6 %, Lymph:11.4 %, Mono:2.6 %,
   Eos:1.1 %, Albumin:3.6 g/dL, LDH:157 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.  Unknown etiology.  On CTX for 5 day
   course.
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg today
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Transfer to liver service now that pt is stable
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  Severe, new dx.
   - CT [**Doctor First Name 213**] c/s for non-emergent intervention
   - cards will continue to follow while on floor
   # BRADYCARDIA.  Down to 50
s while sleeping.
   -          holding anti HTN
   -          EP consult, appreciate recs
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  Cr at 3.4, down from 3.7.  Baseline
   1.7.  Sediment suggestive of ATN given casts, and hypotension at OSH.
   Also consdiered HRS though less likely.   UOP improving over last 24
   hours, 400 since MN.
   - renal following, appreciate recs
   -  Continue trending creatinine [**Last Name (un) **]
   -          IV albumin today
   -          monitor UOP
   -          Hold diuretics
   # ANEMIA.  Stable at 27 this morning.  The patient had a drop in
   hematocrit from 32 to 25 yesterday.  Guaiac neg.  Pt reportedly on
   epogen 10,000u qSaturday.
   - trend daiy
   - will ask renal about why pt on epogen
   # HYPOTENSION:  Resolved.  Likely in setting of SBP.
   -          Hold anti-hypertensives
   -          On ceftriaxone as abov
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - decrease ASA to 81mg
   - Holding anti HTN as above
   - Continue simvastatin 20mg PO daily
   #. PUMP:  EF 65-70%.  AS as above.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   Nutrition:  low salt
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   22 Gauge - [**2134-5-22**] 02:40 PM
   Prophylaxis:
   DVT:  heparin sq
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  FULL
   Disposition: call out to [**Doctor Last Name 976**] [**Doctor Last Name 2578**] service<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 77-year-old female with a chief complaint of cardiogenic shock. The patient has a complex medical history, including coronary artery disease, cirrhosis, type II diabetes, hypertension, and chronic renal insufficiency.

The patient's vital signs are stable, with a temperature of 98.6°F, heart rate of 57 bpm, and blood pressure of 151/55 mmHg. The patient is receiving oxygen therapy and is on telemetry monitoring.

The patient's laboratory results show acute kidney injury with a creatinine level of 3.4 mg/dL, which is an increase from the baseline of 1.7 mg/dL. The urine sediment suggests acute tubular necrosis, and the patient is receiving IV albumin and fluid restriction.

The patient has a diagnosis of aortic stenosis, which is severe and new. The patient is awaiting a non-emergent intervention and will continue to be followed by the cardiology service.

The patient also has a diagnosis of bradycardia, which is being managed with atropine and telemetry monitoring. The patient's cardiac biomarkers were negative at the outside hospital.

The patient's anemia is stable at 27% this morning, and the patient had a drop in hematocrit from 32 to 25 yesterday. The patient is reportedly on epogen 10,000u qSaturday.

The patient's hypotension has resolved, and the patient is no longer receiving anti-hypertensive medications.

The patient's coronary anatomy is as listed previously, and the patient has a history of cardiac biomarkers being negative at the outside hospital.

The patient's pump function is estimated to be 65-70%, and the patient has a diagnosis of aortic stenosis.

The patient's diabetes mellitus type II is being managed with a sliding scale of Humalog per home regimen.

The patient's ICU care includes low-salt nutrition, glycemic control, and prophylaxis for DVT and stress ulcer. The patient is also receiving heparin sodium for prophylaxis and pantoprazole for stress ulcer prophylaxis.

Potential medical complications that can arise from the patient's conditions include:

* Further deterioration of renal function
* Increased risk of bleeding due to the patient's coagulopathy
* Development of sepsis due to the patient's immunocompromised state
* Increased risk of cardiac arrhythmias due to the patient's bradycardia and aortic stenosis
* Development of respiratory failure due to the patient's chronic obstructive pulmonary disease
* Increased risk of gastrointestinal bleeding due to the patient's stress ulcer prophylaxis
* Development of electrolyte imbalances due to the patient's fluid restriction and medication regimen."
158518.0,285503,2134-05-23 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Shock - cardiogenic
   24 Hour Events:
   - Hct drop to 25.9 with am labs. Guaiac neg. Repeat Hct 28.2
   - Fena 0.3
   - Code status confirmed as FULL
   - Renal c/s - More c/w Pre-renal azotemia. Urine sediment with many
   casts more c/w ATN. Less likely HRS given normal BPs and active
   sediment. Added on Urine Eos.
   - Liver c/s - Did not see patient, but suggested midodrine and
   octreotide. Decision deferrred until Liver team can see the patient in
   person
   - EP recs none
   History obtained from Patient
   Allergies:
   History obtained from PatientAmoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2134-5-22**] 10:00 PM
   Heparin Sodium (Prophylaxis) - [**2134-5-22**] 11:19 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-23**] 07:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.7
C (98
   HR: 57 (53 - 60) bpm
   BP: 151/55(77) {102/40(62) - 154/77(90)} mmHg
   RR: 15 (15 - 30) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 77 kg (admission): 79.8 kg
   Height: 61 Inch
                  Total In:
                                                                  1,515 mL
                                                                    260 mL
   PO:
                                                                    840 mL
                                                                    260 mL
   TF:
   IVF:
                                                                    510 mL
   Blood products:
                                                                    165 mL
   Total out:
                                                                    328 mL
                                                                    285 mL
   Urine:
                                                                    328 mL
                                                                    285 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,187 mL
                                                                    -25 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   GENERAL:  a/o x3, comfortable
   SKIN:  mild jaundice, no stigmata of liver disease
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes trace crackles
   ABDOMEN:  Obese; mild distension but soft non-tender. Dull to
   percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   131 K/uL
   9.2 g/dL
   132 mg/dL
   3.4 mg/dL
   17 mEq/L
   4.5 mEq/L
   79 mg/dL
   108 mEq/L
   134 mEq/L
   27.7 %
   8.2 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
                             [**2134-5-22**]  03:00 PM
                             [**2134-5-23**]  05:42 AM
   WBC
   19.0
   9.4
   8.2
   Hct
   32.6
   25.9
   28.2
   27.7
   Plt
   172
   114
   131
   Cr
   3.3
   3.5
   3.7
   3.4
   Glucose
   160
   133
   140
   132
   Other labs: PT / PTT / INR:16.3/31.2/1.5, ALT / AST:15/18, Alk Phos / T
   Bili:73/0.6, Differential-Neuts:84.6 %, Lymph:11.4 %, Mono:2.6 %,
   Eos:1.1 %, Albumin:3.6 g/dL, LDH:157 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.  Unknown etiology.  On CTX for 5 day
   course.
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg today
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Transfer to liver service now that pt is stable
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  Severe, new dx.
   - CT [**Doctor First Name 213**] c/s for non-emergent intervention
   - cards will continue to follow while on floor
   # BRADYCARDIA.  Down to 50
s while sleeping.
   -          holding anti HTN
   -          EP consult, appreciate recs
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  Cr at 3.4, down from 3.7.  Baseline
   1.7.  Sediment suggestive of ATN given casts, and hypotension at OSH.
   Also consdiered HRS though less likely.   UOP improving over last 24
   hours, 400 since MN.
   - renal following, appreciate recs
   -  Continue trending creatinine [**Last Name (un) **]
   -          IV albumin today
   -          monitor UOP
   -          Hold diuretics
   # ANEMIA.  Stable at 27 this morning.  The patient had a drop in
   hematocrit from 32 to 25 yesterday.  Guaiac neg.  Pt reportedly on
   epogen 10,000u qSaturday.
   - trend daiy
   - will ask renal about why pt on epogen
   # HYPOTENSION:  Resolved.  Likely in setting of SBP.
   -          Hold anti-hypertensives
   -          On ceftriaxone as abov
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - decrease ASA to 81mg
   - Holding anti HTN as above
   - Continue simvastatin 20mg PO daily
   #. PUMP:  EF 65-70%.  AS as above.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   Nutrition:  low salt
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   22 Gauge - [**2134-5-22**] 02:40 PM
   Prophylaxis:
   DVT:  heparin sq
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  FULL
   Disposition: call out to [**Doctor Last Name 976**] [**Doctor Last Name 2578**] service
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Shock - cardiogenic
   24 Hour Events:
   - Hct drop to 25.9 with am labs. Guaiac neg. Repeat Hct 28.2
   - Fena 0.3
   - Code status confirmed as FULL
   - Renal c/s - More c/w Pre-renal azotemia. Urine sediment with many
   casts more c/w ATN. Less likely HRS given normal BPs and active
   sediment. Added on Urine Eos.
   - Liver c/s - Did not see patient, but suggested midodrine and
   octreotide. Decision deferrred until Liver team can see the patient in
   person
   - EP recs none
   History obtained from Patient
   Allergies:
   History obtained from PatientAmoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2134-5-22**] 10:00 PM
   Heparin Sodium (Prophylaxis) - [**2134-5-22**] 11:19 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-23**] 07:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.7
C (98
   HR: 57 (53 - 60) bpm
   BP: 151/55(77) {102/40(62) - 154/77(90)} mmHg
   RR: 15 (15 - 30) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 77 kg (admission): 79.8 kg
   Height: 61 Inch
                  Total In:
                                                                  1,515 mL
                                                                    260 mL
   PO:
                                                                    840 mL
                                                                    260 mL
   TF:
   IVF:
                                                                    510 mL
   Blood products:
                                                                    165 mL
   Total out:
                                                                    328 mL
                                                                    285 mL
   Urine:
                                                                    328 mL
                                                                    285 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,187 mL
                                                                    -25 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   GENERAL:  a/o x3, comfortable
   SKIN:  mild jaundice, no stigmata of liver disease
   HEENT:  NCAT. Sclera anicteric. EOMI. Conjunctiva pale.
   NECK:  Supple. No appreciable JVD (exam limited [**2-1**] body habitus)
   CARDIAC:  RRR, normal S1, quiet S2; III/VI holosystolic murmur loudest
   at LUSB
   LUNGS:  Diffuse expiratory wheezes trace crackles
   ABDOMEN:  Obese; mild distension but soft non-tender. Dull to
   percussion, unable to appreciate fluid wave.
   EXTREMITIES:  No lower extremity edema. Radial, DP pulses 2+.
   Neuro:  No asterixis; CNII-XII intact; EOMI; upper and lower extremity
   strength 5/5 and equal bilaterally.
   Labs / Radiology
   131 K/uL
   9.2 g/dL
   132 mg/dL
   3.4 mg/dL
   17 mEq/L
   4.5 mEq/L
   79 mg/dL
   108 mEq/L
   134 mEq/L
   27.7 %
   8.2 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
                             [**2134-5-22**]  03:00 PM
                             [**2134-5-23**]  05:42 AM
   WBC
   19.0
   9.4
   8.2
   Hct
   32.6
   25.9
   28.2
   27.7
   Plt
   172
   114
   131
   Cr
   3.3
   3.5
   3.7
   3.4
   Glucose
   160
   133
   140
   132
   Other labs: PT / PTT / INR:16.3/31.2/1.5, ALT / AST:15/18, Alk Phos / T
   Bili:73/0.6, Differential-Neuts:84.6 %, Lymph:11.4 %, Mono:2.6 %,
   Eos:1.1 %, Albumin:3.6 g/dL, LDH:157 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.  Unknown etiology.  On CTX for 5 day
   course.
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg today
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Transfer to liver service now that pt is stable
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  Severe, new dx.
   - CT [**Doctor First Name 213**] c/s for non-emergent intervention
   - cards will continue to follow while on floor
   # BRADYCARDIA.  Down to 50
s while sleeping.
   -          holding anti HTN
   -          EP consult, appreciate recs
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  Cr at 3.4, down from 3.7.  Baseline
   1.7.  Sediment suggestive of ATN given casts, and hypotension at OSH.
   Also consdiered HRS though less likely.   UOP improving over last 24
   hours, 400 since MN.
   - renal following, appreciate recs
   -  Continue trending creatinine [**Last Name (un) **]
   -          IV albumin today
   -          monitor UOP
   -          Hold diuretics
   # ANEMIA.  Stable at 27 this morning.  The patient had a drop in
   hematocrit from 32 to 25 yesterday.  Guaiac neg.  Pt reportedly on
   epogen 10,000u qSaturday.
   - trend daiy
   - will ask renal about why pt on epogen
   # HYPOTENSION:  Resolved.  Likely in setting of SBP.
   -          Hold anti-hypertensives
   -          On ceftriaxone as abov
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - decrease ASA to 81mg
   - Holding anti HTN as above
   - Continue simvastatin 20mg PO daily
   #. PUMP:  EF 65-70%.  AS as above.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   Nutrition:  low salt
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   22 Gauge - [**2134-5-22**] 02:40 PM
   Prophylaxis:
   DVT:  heparin sq
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:  FULL
   Disposition: call out to [**Doctor Last Name 976**] [**Doctor Last Name 2578**] service<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 77-year-old female with a history of CAD, cirrhosis, DMII, HTN, and CRI, who was transferred to the ICU from the outside hospital with new findings of severe AS, bradycardia, hypotension, leukocytosis, and ARF. She has been on a 5-day course of ceftriaxone for a presumed infection. The patient's condition has been stable, with improvements in her renal function and urine output over the past 24 hours.

Potential Medical Complications:

1. Aortic Stenosis: The patient has severe aortic stenosis, which can lead to decreased cardiac output, decreased blood pressure, and decreased peripheral perfusion.
2. Acute Renal Failure: The patient has acute renal failure, which can lead to electrolyte imbalances, acidosis, and increased risk of cardiovascular events.
3. Bradycardia: The patient's bradycardia can lead to decreased cardiac output, decreased blood pressure, and decreased peripheral perfusion.
4. Hypotension: The patient's hypotension can lead to decreased peripheral perfusion, decreased organ perfusion, and decreased cardiac output.
5. Anemia: The patient's anemia can lead to decreased oxygen delivery to tissues, decreased cardiac output, and increased risk of cardiovascular events.
6. Respiratory Complications: The patient's respiratory status is stable, but she has diffuse expiratory wheezes and trace crackles, which can lead to respiratory failure.
7. Infection: The patient has been on a 5-day course of ceftriaxone, but she may still be at risk for infection, particularly with the presence of a central line and urinary catheter.
8. Liver Failure: The patient has cirrhosis, which can lead to liver failure, encephalopathy, and increased risk of bleeding.
9. Cardiovascular Complications: The patient has a history of CAD and has undergone triple CABG, which can lead to cardiovascular complications such as myocardial infarction, heart failure, and arrhythmias.

Overall, the patient is at risk for a variety of medical complications, and close monitoring and management are necessary to prevent and treat these complications."
158518.0,285503,2134-05-23 07:41:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: Shock - cardiogenic
   24 Hour Events:
   - Hct drop to 25.9 with am labs. Guaiac neg. Repeat Hct 28.2
   - Fena 0.3
   - Code status confirmed as FULL
   - Renal c/s - More c/w Pre-renal azotemia. Urine sediment with many
   casts more c/w ATN. Less likely HRS given normal BPs and active
   sediment. Added on Urine Eos.
   - Liver c/s - Did not see patient, but suggested midodrine and
   octreotide. Decision deferrred until Liver team can see the patient in
   person
   - EP recs none
   History obtained from Patient
   Allergies:
   History obtained from PatientAmoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2134-5-22**] 10:00 PM
   Heparin Sodium (Prophylaxis) - [**2134-5-22**] 11:19 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-23**] 07:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.7
C (98
   HR: 57 (53 - 60) bpm
   BP: 151/55(77) {102/40(62) - 154/77(90)} mmHg
   RR: 15 (15 - 30) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 77 kg (admission): 79.8 kg
   Height: 61 Inch
                  Total In:
                                                                  1,515 mL
                                                                    260 mL
   PO:
                                                                    840 mL
                                                                    260 mL
   TF:
   IVF:
                                                                    510 mL
   Blood products:
                                                                    165 mL
   Total out:
                                                                    328 mL
                                                                    285 mL
   Urine:
                                                                    328 mL
                                                                    285 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,187 mL
                                                                    -25 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   131 K/uL
   9.2 g/dL
   132 mg/dL
   3.4 mg/dL
   17 mEq/L
   4.5 mEq/L
   79 mg/dL
   108 mEq/L
   134 mEq/L
   27.7 %
   8.2 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
                             [**2134-5-22**]  03:00 PM
                             [**2134-5-23**]  05:42 AM
   WBC
   19.0
   9.4
   8.2
   Hct
   32.6
   25.9
   28.2
   27.7
   Plt
   172
   114
   131
   Cr
   3.3
   3.5
   3.7
   3.4
   Glucose
   160
   133
   140
   132
   Other labs: PT / PTT / INR:16.3/31.2/1.5, ALT / AST:15/18, Alk Phos / T
   Bili:73/0.6, Differential-Neuts:84.6 %, Lymph:11.4 %, Mono:2.6 %,
   Eos:1.1 %, Albumin:3.6 g/dL, LDH:157 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   22 Gauge - [**2134-5-22**] 02:40 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: Shock - cardiogenic
   24 Hour Events:
   - Hct drop to 25.9 with am labs. Guaiac neg. Repeat Hct 28.2
   - Fena 0.3
   - Code status confirmed as FULL
   - Renal c/s - More c/w Pre-renal azotemia. Urine sediment with many
   casts more c/w ATN. Less likely HRS given normal BPs and active
   sediment. Added on Urine Eos.
   - Liver c/s - Did not see patient, but suggested midodrine and
   octreotide. Decision deferrred until Liver team can see the patient in
   person
   - EP recs none
   History obtained from Patient
   Allergies:
   History obtained from PatientAmoxicillin
   Unknown;
   Sulfa (Sulfonamides)
   Unknown;
   Iodine; Iodine Containing
   Rash;
   Last dose of Antibiotics:
   Ceftriaxone - [**2134-5-21**] 08:12 PM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2134-5-22**] 10:00 PM
   Heparin Sodium (Prophylaxis) - [**2134-5-22**] 11:19 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2134-5-23**] 07:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.7
C (98
   HR: 57 (53 - 60) bpm
   BP: 151/55(77) {102/40(62) - 154/77(90)} mmHg
   RR: 15 (15 - 30) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 77 kg (admission): 79.8 kg
   Height: 61 Inch
                  Total In:
                                                                  1,515 mL
                                                                    260 mL
   PO:
                                                                    840 mL
                                                                    260 mL
   TF:
   IVF:
                                                                    510 mL
   Blood products:
                                                                    165 mL
   Total out:
                                                                    328 mL
                                                                    285 mL
   Urine:
                                                                    328 mL
                                                                    285 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,187 mL
                                                                    -25 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///17/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   131 K/uL
   9.2 g/dL
   132 mg/dL
   3.4 mg/dL
   17 mEq/L
   4.5 mEq/L
   79 mg/dL
   108 mEq/L
   134 mEq/L
   27.7 %
   8.2 K/uL
        [image002.jpg]
                             [**2134-5-21**]  02:05 PM
                             [**2134-5-22**]  03:26 AM
                             [**2134-5-22**]  03:00 PM
                             [**2134-5-23**]  05:42 AM
   WBC
   19.0
   9.4
   8.2
   Hct
   32.6
   25.9
   28.2
   27.7
   Plt
   172
   114
   131
   Cr
   3.3
   3.5
   3.7
   3.4
   Glucose
   160
   133
   140
   132
   Other labs: PT / PTT / INR:16.3/31.2/1.5, ALT / AST:15/18, Alk Phos / T
   Bili:73/0.6, Differential-Neuts:84.6 %, Lymph:11.4 %, Mono:2.6 %,
   Eos:1.1 %, Albumin:3.6 g/dL, LDH:157 IU/L, Ca++:8.2 mg/dL, Mg++:2.3
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 DIABETES MELLITUS (DM), TYPE II
 AORTIC STENOSIS
 ASCITES
 KNOWLEDGE DEFICIT
   77F with CAD s/p triple CABG, cirrhosis, DMII, HTN, CRI transferred
   from OSH with new finding of severe AS, bradycardia, hypotension,
   leukocytosis, and ARF on CRI, in the setting of increasing shortness of
   breath and abdominal girth.
   # SBP / ASCITES / CIRRHOSIS.
        The patient
s increasing abdominal girth is due to increasing
   peritoneal ascites. Her shortness of breath was probably caused by the
   accumulation of ascites in two ways: (a) via a restrictive process
   where the pressure of the fluid against her lungs and chest wall
   increases the work of breathing; and (b) via the spontaneous bacterial
   peritonitis (SBP) that is present in the ascites, which increases her
   white count, and her non-gap acidosis which causes increased CO2
   production, causes tachypnea to blow off excess CO2, resulting in
   discomfort of breathing.
        In order to evaluate the patient
s ascites, an ultrasound-guided
   paracentesis was performed yesterday. The scan showed ~5L of peritoneal
   fluid, of which approximately 1.4L was removed and showed WBC of >2900
   with 92% poly
s (absolute ~2600 polys) and ascitic fluid total protein
   (AFTP) 1.7. The high number of polys (>250) with low AFTP (<2.5)
   suggests SBP. Measurement of the AFTP assists in differentiating SBP
   from secondary bacterial peritonitis, because lowest protein
   concentration correlates with the highest risk of developing SBP. It is
   thought that the low protein concentration correlates with low
   concentrations of opsonins, which decreases the response of innate
   immunity in the peritoneum and thus predisposes to infection (see
   [**Last Name (un) 7710**], Gastrooenterology [**2110**]; and [**Last Name (un) 7710**], Hepatology [**2112**]). We know
   that most cases of SBP are due to gut bacteria (E. coli, Klebsiella)
   and that sometimes even streptococcus and infrequently staphylococcus
   can be the culprit, so treatment with somewhat broad-spectrum
   antibiotics is warranted at least initially. Therefore, our patient was
   started on ceftriaxone 1g IV daily x5 days (day 1=[**2134-5-21**]).
   Furthermore, patients with cirrhosis and SBP frequently have impaired
   renal function, which often results in increased morbidity and
   mortality. By administering IV albumin (which expands plasma volume and
   increases blood flow to the kidneys), one reduces morality rates at
   three months from 41% to 22% (see Sort et [**Doctor Last Name **], NEJM [**2123**]). Therefore,
   our patient was also given albumin 1.5g/kg yesterday and will receive
   an additional 1.0g/kg on day 3 ([**2134-5-23**]). In terms of long-term
   prophylaxis, the patient will require a weekly dose of 750 mg
   ciprofloxacin for the rest of her life, which will decrease the
   incidence of recurrent SBP from 22% to 3.6% (see Rolachon et [**Doctor Last Name **],
   Hepatology [**2119**]).
        The etiology of her ascites is portal hypertension as evidenced by
   her high gradient SAAG (serum albumin - peritoneal fluid albumin =
   3.4-1.1 = 2.3, where high gradient is >1.1, which has 97% accuracy for
   predicting portal hypertension [see [**Last Name (un) 7710**] et [**Doctor Last Name **], Annals of Internal
   Medicine [**2116**]]). Importantly, high vs. low gradient SAAG is not the
   same as transudative/exudative ascites, which refers specifically to
   AFTP concentration (not albumin). In general, top of the differential
   diagnosis for portal hypertension includes cirrhosis, CHF, and
   alcoholic hepatitis. In our patient, cirrhosis is the most likely
   etiology because the vast majority of patients with SBP have portal
   hypertension secondary to cirrhosis. Furthermore, CHF is an unlikely
   cause (even in the setting of her aortic stenosis) because her EF is
   normal at ~60% and she has low AFTP (CHF is associated with high AFTP).
   Lastly, alcoholic hepatitis is unlikely because she denies a history of
   extensive alcohol abuse.
        The etiology of her cirrhosis, on the other hand, is much more
   elusive. The two most common causes in the USA are alcohol and
   Hepatitis C. Again, a lack of history of alcohol abuse and elicit drug
   abuse make these less likely etiologies. Another possibility is
   nonalcoholic steatohepatitis, but only a biopsy can offer a more
   definitive diagnosis. Given her Cr = 3.5, Tbili = 0.7, INR = 1.7, her
   calculated MELD score is 23, which is associated with ~90% survival at
   3 months (see Kamath et [**Doctor Last Name **], Hepatology [**2125**]).
   -          Continue on ceftriaxone 1 g qd for 5 days (day 1 = [**2134-5-21**])
   -          Albumin 1.0g/kg on [**2134-5-23**]
   -          Will consider Cipro 750 mg qweek after ceftriaxone is
   discontinued
   -          Appreciate recommendation from Dr. [**First Name (STitle) 2578**] (hepatology)
   -          Low salt diet, fluid restriction
   # AORTIC STENOSIS.  The patient has what we believe to be new-onset
   aortic stenosis, with our TTE showing aortic valve area of 0.9cm^2,
   peak gradient ~80 and mean gradient ~50. Given her current infection
   with SBP and lack of severe symptoms related to AS, aggressive
   intervention should be delayed until her infection is cleared.
   Afterwards, she may be evaluated for valvuloplasty (a temporary
   solution) or aortic valve replacement (a more permanent solution). The
   usual indications for AVR surgery include dyspnea on exertion (5 year
   survival from time of diagnosis), angina with exertion (3 year
   survival), or syncope with exertion (1 year survival), or severe LV
   dysfunction from AVR. Given that the running hypothesis is that her
   dyspnea over the past couple of days is due to SBP and the resultant
   tachypnea, she does not have any of these indications for surgery.
   # BRADYCARDIA.  The patient becomes bradycardic during the night to the
   low 40s. This was consistent with what happened at the outside
   hospital, where EKGs suggest junctional rhythm given the lack of P
   waves. This is most likely due to carvedilol
toxicity.
 Given that the
   patient has cirrhosis, she has decreased hepatic metabolism of
   carvedilol, which effectively enhances the doses she receives. Since
   carvedilol is a beta-blocker, she is probably experiencing
   supra-therapeutic effects of the drug that are causing her to become
   bradycardic. We have discontinued her carvedilol and hypothesize that
   her bradycardia should resolve soon. In the future she will need to be
   on a smaller dose, if at all. Given that she also has chronic renal
   failure, switching to a drug that is renally metabolized will probably
   not be a feasible alternative.
   -          hold carvedilol given cirrhosis/ascites
   -          EP consulted for evaluation for pacemaker placement
   -          Hold beta-blocker, calcium-channel blocker
   -          Atropine at bedside
   -          Monitor on telemetry
   # ACUTE ON CHRONIC RENAL FAILURE.  The patient most likely has acute
   (Cr 3.5) on chronic renal failure (baseline Cr 1.7) due to ATN that
   occurred during her episodes of supra-therapeutic drug action causing
   hypotension. Differential also includes ATN secondary to prerenal
   etiology given poor cardiac output secondary to aortic stenosis. [**Month (only) 51**]
   also be secondary to medications - recently started on HCTZ. We will
   send for urine-lytes/osmolarity/Na to further assess.
        The most feared etiology would be hepatorenal syndrome
   (development of acute renal failure in a patient who has advanced liver
   disease due to cirrhosis) because prognosis for these patients is poor,
   with a median survival of 3.3 months (see Alessandria et [**Doctor Last Name **], Hepatology
   [**2129**]). ARF in these patients occurs due to splanchnic vasodilatation
   and increases in nitric oxide circulation, which eventually reduces GFR
   and damages the kidneys. Diagnostic criteria for hepatorenal syndrome
   include a rise in creatinine above 1.5, absence of other causes for
   renal disease (including shock, bacterial infection, SBP, nephrotoxic
   durg use, post-renal obstruction), urine red cell excretion of less
   than 50 cells per HPF, and lack of improvement in renal function after
   volume expansion with IV albumin for at least two days. Given that she
   has a good story for other causes of ARF (i.e. SBP and some component
   of hypotension), the fact that her renal function did not improve with
   IV albumin is not as suggestive of hepatorenal syndrome, because she
   likely has ATN which will take at least a few days to recover.
   Therefore, we will trend her creatinine and we do not expect to see a
   fall until at least 3-5 days (approximately [**Date range (1) 7721**]).
   -          Continue trending creatinine daily
   -          IV albumin tomorrow
   -          Nephrology consult
   -          Urine lytes, UA
   -          Close monitoring of urine output
   -          Hold diuretics
   # ANEMIA.  The patient had a drop in hematocrit from 32 to 25 today.
   This is worrying because it could suggest a GI bleed. She was put on a
   PPI and a type and screen was sent. We will guaiac her stools to check
   for GI bleed.
   -          guaiac stool
   # HYPOTENSION.  The patient
s hypotension has now resolved. She is no
   longer on dopamine. She may have been dehydrated and/or overmedicated.
   Although septic shock was initially suspected given her leukocytosis,
   her WBC has now dropped to 19 and she has no fever. Furthermore, her
   liver disease may play a role in dropping her blood pressure in the
   context of decreased production of albumin.
   -          Hold anti-hypertensives
   -          On ceftriaxone now
   #. CORONARIES:  CAD s/p CABG. Anatomy as listed previously. No chest
   pain currently or prior to OSH admission, although this is not
   necessarily reassuring in this female, diabetic patient. By report,
   cardiac biomarkers were negative at outside hospital.
   - Continue aspirin 325mg PO daily
   - Hold beta-blocker given recent bradycardia, hypotension
   - Continue simvastatin 20mg PO daily
   .
   #. PUMP:  Per signout, patient was thought to be fluid overloaded at
   OSH, BNP 741 with anasarca, net fluid balance +300ml yesterday, +500ml
   today prior to transfer. TTE there showed preserved EF 65-70% but new
   finding of severe AS with valve area of 0.7. Patient with hypotension
   requiring initation of dopamine gtt.
   - Hold beta-blocker given recent bradycardia, hypotension.
   - Hold lasix
   #. Diabetes melliitus, type II:
   - Continue Humalog sliding scale per home regimen
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2134-5-21**] 09:41 PM
   22 Gauge - [**2134-5-22**] 02:40 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

* The patient is a 77-year-old female with a history of cardiogenic shock, aortic stenosis, cirrhosis, diabetes mellitus type II, hypertension, and chronic renal insufficiency.
* She was transferred to the ICU from the outside hospital with new findings of severe aortic stenosis, bradycardia, hypotension, leukocytosis, and acute renal failure.
* The patient's ascites is thought to be due to portal hypertension secondary to cirrhosis, and she was started on ceftriaxone and albumin to treat spontaneous bacterial peritonitis.
* The patient's renal function is impaired, with a creatinine level of 3.5 mg/dL, and she is at risk for developing hepatorenal syndrome.
* The patient's anemia is a concern, and a type and screen was sent to rule out gastrointestinal bleeding.
* The patient's hypotension has resolved, and she is no longer on dopamine.
* The patient's cardiac status is stable, with a preserved EF of 65-70%, but new findings of severe aortic stenosis.
* The patient is on various medications, including aspirin, simvastatin, and Humalog, and she is being managed with a sliding scale insulin regimen.

Potential medical complications that can arise from the patient's condition include:

* Hepatorenal syndrome, which can lead to further decline in renal function and increased mortality.
* Spontaneous bacterial peritonitis, which can lead to sepsis and multi-organ failure.
* Acute kidney injury, which can lead to further decline in renal function and increased mortality.
* Gastrointestinal bleeding, which can lead to hypovolemic shock and multi-organ failure.
* Cardiac complications, such as heart failure or arrhythmias, which can arise from the patient's aortic stenosis and cardiogenic shock.
* Infections, such as pneumonia or urinary tract infections, which can arise from the patient's immunocompromised state.

Overall, the patient's condition is complex and requires close monitoring and management to prevent further complications and improve her outcomes."
